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ABSTRACT
In recent decades, consumption of multivitamin/mineral (MVM) dietary
supplements has significantly increased, reflecting a huge demand from the commercial
market. Meanwhile, there is a big concern of the stability and shelf-life of vitamins,
including fat-soluble vitamins (FSVs), in the dietary supplements. Therefore, it is
necessary to conduct precise analysis and stability evaluation of the FSVs in the
commercial products so as to scrutinize their content levels.
An optimized method to extract the encapsulated FSVs (i.e., vitamin A acetate,
vitamin A palmitate, vitamin D3 and vitamin E succinate) from MVM supplements was
developed in light of four critical factors, including the hydrolysis time by HCl solution,
concentration of HCl solution and hydrolysis temperature, as well as the extraction
solvents. Based on the response surface methodology (RSM), the extraction yields of the
FSVs were fitted to second-order polynomial models, for which an optimized extraction
condition was adopted with the following optimal parameters: 0.4 N HCl solution was used
for MVM tablet samples at 50°C for 2 min. In addition, a mixture of hexane:ethyl acetate
(7:3, v/v) was found to be the best solvent for an efficient extraction of the FSVs from the
MVM supplement. Under this condition, extraction recoveries of the vitamin A esters (i.e.,
retinyl acetate and retinyl palmitate) were determined in a range from 92% to 106%, and
those for the vitamin E succinate and vitamin D ranged from 78% to 90%.
Subsequently, a chromatographic method for simultaneous determination of the
aforementioned four FSVs by high performance liquid chromatography coupled with diode
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array detector was developed and validated in terms of high analytical precision and
accuracy. For the four FSVs, the analytical limit of detection and limit of quantitation were
determined to be in the range of 0.52 - 3.28 µg/mL and 1.56 - 9.94 µg/mL, respectively.
The intra-day and inter-day tests for the analytical precision in terms of their relative
standard deviations were determined to be below 7% for all of the four FSVs.
In order to evaluate the stability of encapsulated FSVs, effects of light, temperature,
pH, and storage conditions on the retention of FSVs were investigated. When dispersed in
water and exposed to light, vitamin A acetate retained only 10% of its original amount after
one day of storage, compared to its retention at 72% stored in darkness. In comparison,
vitamin D3 and vitamin E were more stable than the vitamin A esters under the light
exposure. Vitamin D3 and vitamin E possessed high retentions (72% and 50%,
respectively) when they were exposed to light after 5 days, and even higher values at 78%
and 84% when they were in darkness during the same period. On the other hand, all four
FSVs have shown significantly higher degradations at 30°C, 40°C, and 60°C than at 25°C
in course of the thermal treatment for five consecutive days, but all of their degradation
rates were determined to follow the first-order kinetic models. Moreover, it was observed
that the vitamin A esters were significantly susceptible to the acidic condition (pH 3).
Meanwhile, vitamin D3 and vitamin E succinate showed lower retentions in both acidic
and alkaline conditions (i.e., pH 3, 5, 9) than in the neutral condition (pH 7).
When the FSVs were stored in the form of dry powders, the vitamin D3 and vitamin
E succinate powders exhibited the highest retentions at 79.4% and 71.2%, respectively,
when they were stored in whirl-pak bags under the 25°C/60% RH condition compared to
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other four storage conditions, including 30°C/65% RH, 30°C/75% RH, 40°C dry,
40°C/75% RH. In addition, the vitamin A acetate and vitamin A palmitate possessed 61.1%
and 57.2% of their original amounts, respectively, under the 25°C/60% RH condition,
which were significantly higher than their counterparts under the 30°C/75% RH and
40°C/75% RH conditions. Moreover, the degradation rate of each FSV under the
aforementioned five conditions was determined to follow the first-order kinetics.
Under the full factorial design test, it was found that the storage condition, storage
time, and packaging material could significantly impact the stability of vitamin A esters
(i.e., acetate form and palmitate form) in their MVM tablets. Results also demonstrated
that higher temperature/humidity could significantly speed up the degradation of vitamin
A esters. For example, the vitamin A palmitate had its significantly lower remaining
residue at the 30°C /75% RH condition than those at other storage conditions (i.e.,
25°C/60% RH and 30°C/65% RH), when it was stored in HDPE bottles, PETE bottles,
blister package, and PET pouch. Nevertheless, glass has provided the best protection
against oxygen, heat and humidity for the vitamin A esters under darkness. It provided
significantly higher retention of the vitamin A palmitate than other four packaging
materials regardless of the storage conditions in terms of temperature/humidity. In
comparison, the vitamin A acetate showed a similar situation. In addition, when the
temperature and humidity were raised, the power of protection of the packaging materials
for the vitamin A esters were ranked in the following order: HDPE>PETE>blister>PET
pouch.

iv

DEDICATION
I would like to dedicate this work to my family members for their love and
encouragement, especially to my parents Xiuling Wang and Ruinan Ai for their endless
love, support and everything. They are always stand by my side no matter what happened.
This long journey would not been possible without them.

v

ACKNOWLEDGMENTS
First, I am deeply indebted to my major advisor and committee chair, Dr. Feng
Chen, who has the attitude and the substance of a genius. I want to express my greatest
appreciation to you for offering me the opportunity to join this research group and guiding
me through my study. Your extensive professional and personal guidance, mentoring, and
patience taught me a lot in both scientific research and life. Without your guidance,
suggestions and persistent help this dissertation would not have been possible. As my
mentor, you have taught me more than I could ever give credit for.
I would also like to thank my committee members, Dr. Haiying Liang, Dr. William
Bridges and Dr. Xi Wang, for your support and great suggestions on every aspect. I
appreciate your time to review my work and provide valuable comments.
Finally, I want to appreciate the help and support from Dr. Chen’s research group,
especially Dr. Qingran Meng, and my lab-mates Dr. Lina Wang, Mr. Weizheng Wang, and
Dr. Bolim Lee, Thank you for all kinds of assistance and friendship as always.

vi

TABLE OF CONTENTS
Page
TITLE PAGE ................................................................................................................i
ABSTRACT ............................................................................................................... ii
DEDICATION ............................................................................................................. v
ACKNOWLEDGMENTS ........................................................................................... vi
LIST OF TABLES ......................................................................................................ix
LIST OF FIGURES .................................................................................................... xi
CHAPTER
I.

LITERATURE REVIEW............................................................................ 1
1.1 Vitamin A ....................................................................................... 2
1.2 Vitamin D ....................................................................................... 7
1.3 Vitamin E...................................................................................... 11
1.4 Multivitamin/mineral Dietary Supplements ................................... 17
1.5 Objectives of the Project ............................................................... 23
References .......................................................................................... 33

II.

OPTIMIZATION OF EXTRACTION METHOD FOR SIMULTANEOUS
DETERMINATION OF FAT-SOLUBLE VITAMINS IN
MULTIVITAMIN DIETARY SUPPLEMENTS ................................. 43
Abstract .............................................................................................. 43
2.1 Introduction................................................................................... 44
2.2 Materials and Methods .................................................................. 46
2.3 Results and Discussion .................................................................. 53
2.4 Conclusion .................................................................................... 67
References .......................................................................................... 90

III.

STABILITY STUDY OF ENCAPSULATED FAT-SOLUBLE VITAMINS
........................................................................................................... 94
Abstract .............................................................................................. 94
3.1 Introduction................................................................................... 95

vii

Table of Contents (Continued

Page

3.2 Materials and Methods .................................................................. 98
3.3 Results and Discussion ................................................................ 104
3.4 Conclusion .................................................................................. 112
References ........................................................................................ 124
IV.

STABILITY STUDY OF TWO VITAMIN A ESTERS OF DIETARY
SUPPLEMENT IN SOLID DOSAGE FORM (TABLETS)............... 127
Abstract ............................................................................................ 127
4.1 Introduction................................................................................. 128
4.2 Materials and Methods ................................................................ 131
4.3 Results and Discussion ................................................................ 132
4.4 Conclusion .................................................................................. 138
References ........................................................................................ 146

viii

LIST OF TABLES
Table

Page

2.1

Literature review....................................................................................... 70

2.1

Literature review (Continued) ................................................................... 71

2.2

Comparison of treatments to remove the encapsulation coatings of FSVs.. 73

2.3

Effects of different extraction solvents on the extraction efficiency of four
FSVs from MVM supplement samples ................................................ 77

2.4

Box–Behnken Design of RSM for FSVs and the actual values vs. predicted
values.................................................................................................. 78

2.5

ANOVA table for response surface quadratic model of the vitamin A acetate
........................................................................................................... 79

2.6

ANOVA table for response surface quadratic model of the vitamin A
palmitate ............................................................................................. 80

2.7

ANOVA table for response surface quadratic model of the vitamin D3...... 81

2.8

ANOVA table for response surface quadratic model of the vitamin E
succinate ............................................................................................. 82

2.9

Calibration data, LOD, LOQ of the four FSVs .......................................... 87

2.10

Intra-day and inter-day precision determined at three concentration levels 88

2.11

Extraction recovery (%) of the four FSVs spiked at three different levels into
the MVM supplements samples........................................................... 89

3.1

Reaction rate constants and coefficient of determination for the four FSVs at
different temperatures ....................................................................... 118

3.2

Retention of FSVs powder in different conditions at the end of the designated
time pan (93 days)............................................................................. 120

3.3

Reaction rate constants and coefficients of determination (R2) of the four FSV
powders stored in five different conditions ........................................ 123

ix

List of Tables (Continued)
Table

Page

4.1

Vitamin A acetate retention percentage (%) observed after storage for 24
months in five different packaging materials and three storage conditions
......................................................................................................... 142

4.2

Vitamin A palmitate retention percentage (%) observed after storage for 24
months in five different packaging materials and three storage conditions
......................................................................................................... 145

x

LIST OF FIGURES
Figure

Page

1.1

Structures of retinol and retinyl esters ....................................................... 25

1.2

UV Absorption spectra of retinyl esters standards ..................................... 26

1.3

Parent steroid nucleus ............................................................................... 27

1.4

Chemical structures of vitamin D2 and vitamin D3 .................................... 28

1.5

UV Absorption spectra of vitamin D3........................................................ 29

1.6

Eight forms of vitamin E........................................................................... 30

1.7

Chemical structure of d-a-tocopherol succinate ........................................ 31

1.8

UV Absorption spectra of d-a-tocopheryl succinate .................................. 32

2.1

Chromatogram of mixed standards of four FSVs....................................... 72

2.2

Effect of the HCl solution concentration on the extraction efficiency of four
FSVs from MVM supplement ............................................................. 74

2.3

Effect of the hydrolysis time on the extraction efficiency of four FSVs from
the ground MVM supplement samples ................................................ 75

2.4

Effect of the temperature on the extraction efficiency of four FSVs from
MVM supplement samples .................................................................. 76

2.5

Response surface plots of vitamin A acetate extraction yield..................... 83

2.6

Response surface plots of vitamin A palmitate extraction yield ................. 84

2.7

Response surface plots of vitamin D3 extraction yield ............................... 85

2.8

Response surface plots of vitamin E succinate extraction yield ................. 86

3.1

Degradation of vitamin D3 and its isomerization products ....................... 114

3.2

Photochemical degradations of four FSVs............................................... 115

xi

List of Figures (Continued)
Figure

Page

3.3

Thermal degradations of four FSVs in aqueous system under four different
temperatures...................................................................................... 116

3.4

Degradation of the FSVs in aqueous system at four temperatures following a
first-order kinetic model .................................................................... 117

3.5

Degradation of FSVs in aqueous system at four pH levels....................... 119

3.6

Degradation of water dispersible FSVs stored in different conditions followed
by first-order kinetic model ............................................................... 121

3.6

Degradation of water dispersible FSVs stored in different conditions followed
by first-order kinetic model (continued) ............................................ 122

4.1

Remaining percentage of sample A (MVM tablet with vitamin A acetate) in
five different packaging stored in three conditions throughout 24 months
......................................................................................................... 140

4.2

Degradation rates of vitamin A acetate in sample A in different condition and
packages. .......................................................................................... 141

4.3

Remaining percentage of sample B (MVM tablet with vitamin A palmitate) in
five different packaging stored in three conditions (25/60, 30/65, 30/75)
throughout 24 months ....................................................................... 143

4.4

Degradation rates of vitamin A palmitate in sample B in different condition
and packages. .................................................................................... 144

xii

CHAPTER ONE
LITERATURE REVIEW
Vitamins are a group of organic compounds that perform specific and essential
roles in biological organisms, including human beings. Since most of the important
vitamins can be synthesized neither in our bodies nor in sufficient quantities, they must be
obtained through diets or other supplementary sources in order to maintain normal
development in the body. The vitamins are normally classified based on their biological
and chemical activities instead of their structures. The two main groups categorized based
on their solubility are water-soluble and fat-soluble vitamins (FSVs). The latter mainly
contains Vitamin A, D, E, and K in different forms.
A lot of research has revealed the health benefits of taking certain vitamincontaining supplements along with regular diet, which has prompted a significant increase
in consumption of dietary supplements to a great extent throughout the last decades.
Among those various supplements, multivitamin/mineral (MVM) supplements are the
most popular ones ever since they became available in the early 1940s (McGinnis et al.,
2006). According to the National Health and Nutrition Examination Survey (NHANES III)
results and many other scientific reports, approximately 50% of the US population
consumes essential vitamins and minerals along with their regular diet to compensate for
unhealthy eating habits (Earnest, Cooper, Marks, & Mitchell, 2002). However, no
regulatory definition or standard has been established for MVM supplements, such as the
amount of active ingredients or what kind of nutrients should be contained. On the other
hand, a wide variety of formulations with varied components and characteristics have been
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developed for the market. Since various forms of vitamin A, D, and E along with other
complex components have been practically added into MVM dietary supplements as the
common ingredients, it has not only prompted multiple analytical methods and/or
procedures to analyze diversified MVM samples in practice, but also resulted in higher
analytical variability.
1.1 Vitamin A
1.1.1 Structure and physicochemical properties of vitamin A
Vitamin A refers to a group of compounds such as retinol, retinoic acid, retinal, and
provitamin A carotenoids that exhibit the biological activity of all-trans retinol (Eitenmiller
& Landen, 2010). The term “retinoids” consists of both naturally occurring compounds
that possess vitamin A activity, and synthetic retinol derivatives with or without vitamin A
activity (Genestar & Grases, 1995). The parent compound of the vitamin A family, retinol,
contains a b-ionone (cyclohexenyl) ring (Ball, 2005) with a polyene side chain of three
isoprenoid units attached at the 6-position of the b-ionone ring (Eitenmiller & Landen,
2010). The empirical formula of retinol is C20H30O, of which the molecular weight (MW)
is 286.4. The conjugated double-bond system consists of the 5,6-b-ionone ring carbons as
well as the isoprenoid side chain (Nollet, 2004). The all-trans retinol possesses the
maximum vitamin A activity (Ball, 2005). Since free retinol is a polyunsaturated
compound which is chemically unstable, it is susceptible to oxidation when exposed to
atmospheric oxygen (Ball, 2005). As a result, its ester forms, primarily the retinyl palmitate,
are widely existing in foods of animal origin in an effort to keep its biological activity and
stability. A retinyl ester is a storage form of retinol that has a fatty acyl group esterified to
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the hydroxyl terminus of retinol (Figure 1.1) (O'Byrne & Blaner, 2013). For example,
retinyl palmitate (formula C36H60O2) is the ester of the alcohol form of vitamin A retinol
and palmitic acid. Similarly, retinyl acetate is the acetate ester of retinol. These retinyl
esters are more stable towards oxidation than retinol. Therefore, the all-trans-retinyl acetate
and all-trans-retinyl palmitate are the most popular retinyl esters used toward food
fortification in nutraceutical and pharmaceutical industries. Retinol and retinyl acetate are
yellow crystalline powders whereas retinyl palmitate is a pale yellow crystalline mass or
viscous liquid oil (Ball, 2005). Retinol and its esters are insoluble in water but soluble in
chloroform, ether, acetone, fats, and oils; and slightly soluble in alcohol (Ball, 2005).
1.1.2 Nutritional and physiological functions of vitamin A
Vitamin A must be acquired regularly from the diet to maintain essential
physiological processes in the human body and can be stored in the body as retinol and
retinyl esters forms, which are also called retinoid together, in relatively high level. Several
natural and synthetic forms of retinoid have been demonstrated to exert profound influence
on healthy skin, normal vision, immune function, normal reproduction, inhibiting cell
proliferation, cellular differentiation and apoptosis (D’Ambrosio, Clugston, & Blaner,
2011; Olson, 1987; Wang, 2005). Of those retinoids, retinol and retinyl esters such as those
of palmitic acid, oleic acid, linoleic acid, and stearic acid are the most abundant forms
present in the human body (Blaner & Olson, 1994; Vogel, Gamble, & Blaner, 1999). The
retinyl esters exist in the storage forms of retinol in livers and extrahepatic tissues
(Kurlandsky, Duell, Kang, Voorhees, & Fisher, 1996). They serve as the substrate of
RPE65 retinoid isomerase to produce the visual chromophore 11-cis-retinal, which is a
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visual pigment formed from all-trans-retinyl ester after a series of hydrolysis and
isomerization (O'Byrne & Blaner, 2013; Palczewski, 2012).
1.1.3 Occurrence of vitamin A in foods and RDA
Vitamin A is found in a large amount in the liver of meat animals, since the liver is
the primary storage site of the vitamin in the body (Ball, 2005). In plants, it occurs in the
form of provitamin A carotenoids that are found frequently in carrots, sweet potatoes, and
dark green leafy vegetables in the American diet (Block, 1994). Dairy products such as
butter, whole milk, eggs, and cheese are also important sources of vitamin A. In addition,
fortified food such as cereals, powdered breakfast drinks, margarine, and skim milk are
often fortified with vitamin A to deliver a certain amount to a large number of people on a
daily basis (Dary & Mora, 2002).
The recommended dietary allowance (RDA) for Vitamin A is 900 µg retinol
activity equivalents (RAE)/day for adolescent and adult males, 700 µg RAE/day for female
of same age group (Institute of Medicine [IOM], 2001a). Vitamin A is fat soluble;
therefore, the excess intake will be stored and accumulated primarily in the liver, resulting
in significant toxicity known as hypervitaminosis A. Chronic consumption of excess
vitamin A can lead to hypercalcemia, bone abnormalities, increased intracranial pressure,
nausea, skin irritation, comas and even death (Feskanich, Singh, Willett, & Colditz, 2002;
Melhus et al., 1998). In addition to the excessive dietary intakes, the hypervitaminosis can
also be associated with consuming excessive preformed vitamin A from dietary
supplements or therapeutic retinoids. The Food and Nutrition Board (FNB) has established
Tolerable Upper Intake Levels (ULs) for preformed vitamin A (mainly retinol and retinyl
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esters) that apply to both food and dietary supplement intakes to be 3000 µg RAE/day for
adult male and female (IOM, 2001a).
1.1.4 Analytical method of vitamin A
The traditional technique to prepare vitamin A analysis is saponification followed
by solvent extraction. This method is usually applied when determining the total retinol.
However, vitamin degradation and isomerization readily occur during the saponification
step. Therefore, several kinds of antioxidants, such as BHT, ascorbic acid, and
hydroquinone, has been proven and applied to inhibit the oxidation and isomerization when
preparing the samples. Alternatively, direct extraction without the saponification process
provides another way to separate and identify the retinol and different retinyl esters
(Genestar & Grases, 1995). It was reported in the previous literature that hexane is
generally used as an extraction solvent after the protein is denatured by ethanol (Eitenmiller
& Landen, 2010).
Various methods for vitamin A analysis, such as classical colorimetric,
fluorometric, thin-layer chromatographic, and spectrophotometric techniques, have been
developed in the past (Eitenmiller & Landen, 2010). As the high-performance liquid
chromatography (HPLC) methodology was rapidly developed over the past decades, its
highly efficient property has prompted it to become the most powerful tool for vitamin A
analysis. The presence of the conjugated double-bond system of the retinoids contributes
to strong molar absorptivity of the compound at ultraviolet (UV) wavelength and visible
wavelength, which has been applied to HPLC qualitative and quantitative analysis (Van
Breemen et al., 1998). The maximal absorption for retinoids varies from 318 nm to greater
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than 369 nm depending on the structural variation due to the presence of cis-isomers, as
well as the solvent used (Eitenmiller & Landen, 2010). In common, the wavelengths used
for HPLC detection of all-trans-retinol, retinyl palmitate and retinyl acetate (Figure 1.2a
and 1.2b) are all 325 nm. Besides the ultraviolet–visible (UV-Vis) detection, diode array
detection (DAD) is another similar spectrometric mode that can be used to identify and
analyze retinoids (Van Breemen et al., 1998).
1.1.5 Stability and degradation of vitamin A
The stability of vitamin A can be influenced by various factors during processing
and storage. The presence of oxygen, moisture, light (especially UV radiation), high
temperature and low pH can lead to vitamin A degradation. Isomerization can readily occur
due to the existence of the double bond, especially under acidic conditions in the aqueous
form (Ottaway, 1993). The predominant cis isomer is neovitamin A (13-cis) that accounts
for 75% of biological activity of the all-trans form, while other possibly formed isomers
such as 6-cis, 2,6-di-cis isomers have less than 25% biological activity of the all-trans
vitamin A (Ottaway, 1993). Atmospheric oxygen is a crucial factor causing vitamin A to
be decomposed. However, retinyl esters are more stable than retinol. On the other hand, it
was reported that trace minerals, such as metal sulphates of copper, zinc, and iron, could
act as catalysts in the decomposition of retinol (Marchetti, Ashmead, Tossani, Marchetti,
& Ashmead, 2000). However, the loss of retinol that were stored with metal amino acid
chelates was significantly less than that stored with metal sulphates at different
temperatures (Marchetti et al., 2000). Nevertheless, both retinol and retinyl esters are
sensitive to the ultraviolet component of light (Fellman, Dimick, & Hollender, 1991). A
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study regarding the effect of fluorescent light on retinyl palmitate fortified in skim milk
showed that the level of all-trans retinyl palmitate decreased while the 9-cis isomer
increased during the light exposure for 48 hours (Gaylord, Warthesen, & Smith, 1986).
1.2 Vitamin D
1.2.1 Structure and physicochemical properties of vitamin D
Vitamin D refers to a group of fat-soluble secosteroids that display antirachitic
activity, as well as being responsible for enhancing intestinal absorption of minerals such
as calcium, phosphate and magnesium (Rucker, Zempleni, Suttie, & McCormick, 2007).
They are derived from the cyclopentanoperhydro-phenanthrene ring system (Figure 1.3)
which is a common structure to other steroids, with cholesterol being the parent compound
(Eitenmiller & Landen, 2010). Compared to the cholesterol, vitamin D only has three intact
rings due to the fission of the 9, 10-carbon bond of the B ring of cholesterol. This leads to
the formation of the conjugated triene system in all of the vitamin D family in nature, which
has various forms highlighted by their different side chain structures. Among those forms,
vitamin D2 (ergocalciferol, C28H44O, MW=396.6) and vitamin D3 (cholecalciferol,
C27H44O, MW=384.2) are the most important ones in humans. Both of them are naturally
occurring with 5, 6 double bond in the cis configuration (Ball, 2005). The only structural
difference of those two is that vitamin D2 has a double bond and an extra methyl group in
the C-17 side chain (Figure 1.4). Both crystalline vitamin D2 and D3 are white to yellowish
powder, which are soluble in acetone, oils and fat, and 95% ethanol, readily soluble in ether
and chloroform, and insoluble in water.
1.2.2 Nutritional and physiological functions of vitamin D
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Vitamin D3 can be synthesized in the skin when exposed to sunlight or ultraviolet
light, and vitamin D2 is obtained from plants through the UV irradiation of the plant steroid,
yeast sterol ergosterol (Holick et al., 2011; Trump & Johnson, 2010). In order to perform
its biological effect, vitamin D3 must be hydroxylated at its C-25 position into 25hydroxyvitamin D (25(OH)D) in the liver, and subsequently at its C-1 position into 1,25dihydroxyvitamin D (1,25(OH)2D in the kidney (Lips, 2006). Sufficient level of vitamin D
provides essential protection for the human body by preventing bone disease, diabetes, and
cancer (Garland et al., 2006; Pittas, Lau, Hu, & Dawson-Hughes, 2007). It also promotes
calcium absorption and maintains the serum calcium level to ensure normal mineralization
of the bone (Christakos, Dhawan, Porta, Mady, & Seth, 2011). Evidence has shown that
along with calcium, vitamin D can serve as a preventive treatment for osteoporosis among
elder people (Tang, Eslick, Nowson, Smith, & Bensoussan, 2007).
Vitamin D deficiency that is defined as a 25(OH)D level less than 20 ng/ml still
commonly occurs worldwide and becomes a prevalent condition in all age groups of the
U.S. population (Lee, O'Keefe, Bell, Hensrud, & Holick, 2008). Based on previous studies,
40% to 100% of US, European and Canadian elderly people who are still living in the
community instead of the nursing homes are experiencing vitamin D deficiency (Holick,
2007). Vitamin D deficiency results in rickets among children as well as precipitation and
exacerbation of osteopenia, osteoporosis, and fractures among adults (Bakhtiyarova,
Lesnyak, Kyznesova, Blankenstein, & Lips, 2006; Chen et al., 2007; Holick, 2006; Holick
& Chen, 2008; Larsen, Mosekilde, & Foldspang, 2004). Proximal muscle weakness,
increased risk of falling and skeletal mineralization defects are associated with the vitamin
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D deficiency (Broe et al., 2007; Visser, Deeg, & Lips, 2003). It is also believed that vitamin
D deficiency is correlated with the increased risk of developing breast, prostate, colorectal
and other common cancers (Ahonen, Tenkanen, Teppo, Hakama, & Tuohimaa, 2000;
Garland et al., 2006).
1.2.3 Occurrence of vitamin D in foods and RDA
Although a small amount of vitamin D can be obtained from natural foods, the
primary source of vitamin D for human beings comes from the vitamin D3 that can be
synthesized in the skin through UV irradiation, especially UVB (290-315 nm) (Chen et al.,
2007). Fatty fish such as sardines, herring, and tuna or some types of sundried mushrooms
(shiitake) are considered to be some rare vitamin D-rich foods (Chen et al., 2007; LambergAllardt, 2006; Wacker & Holick, 2013). Fluid milk is fortified with vitamin D by law in
the United States and Canada to meet the requirement of RDA. Also, dairy products such
as skim milk powder, infant formulas, evaporated milk, and breakfast cereals are also
commonly enriched with vitamin D (Ball, 2005). In fortified food and dietary supplements,
vitamin D usually exists in either vitamin D2 or vitamin D3 form.
1.2.4 Analytical methods of vitamin D
As vitamin D is a lipophilic and highly reactive molecule, it is historically
problematic to extract vitamin D from foodstuff with all the other lipid compounds
excluded, followed by a strenuous separation and detection process utilizing ultraviolet
absorption technology (Byrdwell et al., 2008). The Association of Official Analytic
Chemists (AOAC) International has already validated several methods including chemical
and microbiological ones regarding detection of vitamin D from mixed feeds, premixes,
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milk-based infant formula, milk and cheese. In these methods, saponification was used
exclusively as the initial step to treat the sample, especially those containing high fat
content. Followed by the saponification, solid-phase extraction (SPE) is commonly used to
clean up and concentrate the unsaponifiable residual. Other methods such as gel permeation
chromatography and semipreparative LC can also be applied to purify the sample (Nollet,
2004). Previous literature presented several methods for vitamin D analysis, such as
competitive protein binding assay, gas chromatograph, etc (Belsey, Deluca, & Potts Jr,
1971; Nair, Bucana, de Leon, & Turner, 1965). Since both reverse- and normal-phase
HPLC can provide efficient resolution of Vitamin D separation, HPLC has become the
major analytical method for vitamin D detection nowadays. For example, previous research
reported that, after the sample was saponified, subsequently extracted with hexane and
diethyl ether, and then fractionated by SPE followed by semipreparative LC with silica
Rad-pak column, vitamin D2 and D3 could be separated on a C18 column and analyzed by
a UV detector (Kurmann & Indyk, 1994). Another assay was described to measure vitamin
D2, D3 and their metabolites in human plasma by HPLC coupled with UV detector and
confirmed by mass spectrometry (Jones, 1978). Commonly, the wavelength for HPLC-UV
detection for vitamin D is 265 nm (Figure 1.5).
1.2.5 Stability and degradation of vitamin D
Both vitamin D2 and D3 can be destroyed by atmospheric oxygen. Crystalline
vitamin D2 presents signs of decomposition in the presence of air after several days storage
at ambient temperatures (Ottaway, 1993). Crystalline cholecalciferol (vitamin D3) is
relatively more stable than crystalline vitamin D2, probably due to less quantities of double
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bonds in the structure of the former chemical. Exposure to light and heat also lead vitamin
D to rapid degradation and isomerization into the its inactive forms (Renken & Warthesen,
1993; Semo, Kesselman, Danino, & Livney, 2007). Vitamin D3 was found to be unstable
to light, oxidation and acid in a study of vitamins in bovine and human milk (Cremin &
Power, 1985). In an acidic environment, vitamin D can be isomerized to isotachysterol (Jin,
Yang, Yang, Liu, & Zhang, 2004). Also, it has been reported that high humidity and
elevated temperatures could lead to decomposition of ergocalciferol, forming higher
polarity products in solid drugs (Grady & Thakker, 1980).
However, a previous study has shown that vitamin D was not lost during the hightemperature, short-time (HTST) processing of vitamin D fortified milk and ultrahigh
temperature (UHT) processed chocolate milk. In addition, vitamin D was relatively stable
throughout the shelf life of both products (Hanson & Metzger, 2010). Another research
reported that vitamin D3 in its fortified natural hard cheese did not degrade during the
processing and ripening (3-8°C over one year) stages and after high temperature treatment
at 232°C for 5 min (Wagner et al., 2008). Moreover, another study with regard to
fortification of vitamin D3 in pasteurized processed cheese reported that no loss of vitamin
D3 occurred during the storage period of 9 months at both 21-29°C and 4-6°C (Upreti,
Mistry, & Warthesen, 2002).
Previous individual studies have presented contradictory results, suggesting the
stability of vitamin D greatly depends on the food types which it is present in (Kazmi,
Vieth, & Rousseau, 2007).
1.3 Vitamin E
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1.3.1 Structure and physicochemical properties of vitamin E
The vitamin E family consists of two groups, tocopherols and tocotrienols. Those
two groups include four naturally occurring tocopherols and their corresponding
tocotrienols. All eight natural forms of vitamin E feature a chromanol ring containing a
hydroxyl group and a 12-carbon aliphatic side chain. The tocopherols have saturated side
chains whereas the tocotrienols possess unsaturated isoprenoid side chains containing three
trans double bonds (Aggarwal, Sundaram, Prasad, & Kannappan, 2010). The four
tocopherols and four tocotrienols both contain a-, b-, g-, and d- forms, which differ in the
arrangement and number of the methyl groups attached to the chromanol ring (Figure 1.6).
The alpha form contains trimethyl groups, the beta form and gamma form have dimethyl
groups, whereas the delta form possesses a monomethyl group (Aggarwal et al., 2010).
Tocopherols and tocotrienols, as well as a-tocopherol acetate, are normally clear
pale yellow, odorless, viscous oil in the pure state (Ball, 2005). The nonesterified
tocotrienols and tocopherols are insoluble in water but readily soluble in ethanol or other
organic solvents, such as acetone and chloroform (Ball, 2005). In the supplement and
fortified food sectors, dry white granular powders of ester form of vitamin E are commonly
used in compressed tablets, since they have better flow ability and stability during
manufacturing process.
Commercially, vitamin E supplements usually contain esterified forms of vitamin
E derivatives, such as a-tocopheryl acetate (a-TA), a-tocopheryl succinate (a-TS), and atocopheryl nicotinate (a-TN). For example, d-a-TS (Figure 1.7), which is the ester form
of d-a tocopherol combined with succinic acid, is the primary ingredient in our MVM
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sample. Its wavelength of maximum absorption is 285 nm (Figure 1.8). Nevertheless,
those ester forms can be readily hydrolyzed in the body and then absorbed as a-tocopherol
(Cheeseman et al., 1995).
1.3.2 Nutritional and physiological functions of vitamin E
As the most abundant form existing in nature, a-tocopherol exhibits the highest
biological activity (Burton & Traber, 1990). By donating the phenolic hydrogen atom of
a-tocopherol to the peroxyl radicals, hydroperoxide products are formed along with the
tocopheroxyl radicals, which react with another peroxyl radical in order to form inactive
products (Burton & Traber, 1990). Among various commercially available chain-breaking
antioxidants, vitamin E has been considered to be one of the most efficient ones (Burton &
Ingold, 1981). Ester forms of vitamin E do not possess antioxidant properties because their
active phenol group is blocked after the esterification (Turley et al., 1995). However, after
the hydrolysis of the esters by the pancreatic esterases in the intestine, free alcohol forms
of vitamin E can be released, which restore their antioxidant activities (Schneider, 2005).
Many research on a-tocopheryl succinate (a-TS), which is the ester form of a-tocopherol
combined with succinic acid, has indicated that it is the most effective vitamin E form for
adjuvant cancer treatment (Prasad, Kumar, Yan, Hanson, & Cole, 2003). Back in 1982, aTS was reported to be capable of inducing morphological and biochemical differentiation,
as well as inhibition of proliferation and apoptosis of murine melanoma cells in culture
(Prasad & Edwards-Prasad, 1982). During the 1980s, a-TS was found to be able to inhibit
the growth and lead to morphological changes in rat glioma (C-6) cells and mouse
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neuroblastoma (NBP2) in culture (Rama & Prasad, 1983). Another paper also exhibited
the effectiveness of a-TS treatment in the suppression of the radiation-induced
transformation of the mouse C3H/10T12 cells (Radner & Kennedy, 1986). Several articles
have revealed the mechanism of the inhibitory effect of a-TS on various tumor cells, such
as retrovirus-transformed tumor cells (Kline, Cochran, & Sanders, 1990), human B
lymphoma cells (Turley et al., 1995), human breast cancer cells (Turley et al., 1997; Yu et
al., 1999) and human prostate cancer cells (Israel, Yu, Sanders, & Kline, 2000; Zhang et
al., 2002).
1.3.3 Occurrence of vitamin E in foods and RDA
Cereal grains are the main plant sources of vitamin E. In addition, nuts, seeds, beans
and the vegetable oils extracted from them are among the major dietary sources of vitamin
E. Due to the high level of polyunsaturated fatty acid in vegetable oils, vitamin E exists in
high concentrations and is helpful to inhibit the lipid autoxidation. Besides the
aforementioned dietary sources of vitamin E, green leafy vegetables, meat, fish, dairy
products and eggs also provide substantial amounts of vitamin E. Fish is a better source
compared to meat. Vitamin E deficiency is rare in all groups other than infants or premature
babies with very low birth weights (Brion, Bell, & Raghuveer, 2003). Other situations that
may cause vitamin E deficiency are disorders of fat metabolism and fat malabsorption.
People with such disorders have an extremely poor ability to absorb vitamin E, or dietary
fat that is required for vitamin E absorption in the digestive tract (Kowdley, Mason,
Meydani, Cornwall, & Grand, 1992; IOM, 2001a). The RDA for vitamin E as alpha-
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tocopherol form is 15 mg (22.4 IU) for both males and females of 14 years old and above
(Institute of Medicine [IOM], 2001b).
1.3.4 Analytical methods of vitamin E
Various extraction methods for vitamin E have been described depending on the
category of the sample matrix. Traditionally, saponification has been mainly applied to
treat food samples by heating under alkaline (typically KOH) condition in ethanol or
methanol. Since saponification is time-consuming and readily causes oxidation of vitamin
E, some other methods without saponification have been developed for sample treatment.
For example, vitamin E was extracted from serum simply by hexane without saponification,
resulting in a similar yield to that of normal extraction (De Leenheer, De Bevere, De Ruyter,
& Claeys, 1979). Hexane, or sometimes mixed with other more polar solvents such as
ethanol, ethyl acetate, have been used to achieve direct extraction of tocopherols from
wheat products, blood serums and plasma samples (Hakansson, Jagerstad, & Oste, 1987;
Ueda & Igarashi, 1990). Previous literature has described different methods for analysis of
vitamin E using thin-layer chromatography, colorimetry, gas chromatography (GC), as
well as HPLC which is considered the most precise and specific method (Lee, Ye, Landen,
& Eitenmiller, 2000). Separations of tocopherols can be performed using HPLC with either
normal-phase (NP) or reversed-phase (RP) columns. In spite of wide application of the RP
columns in light of the advantages of their prominent stability and durability, the RP
columns are not applicable to separate the two forms of tocopherols and tocotrienols: the
b- and g-isomers (Kramer, Blais, Fouchard, Melnyk, & Kallury, 1997). In contrast, the NP
column offers better separation of all isomers. Previous research showed that fluorescence
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detectors perform better than the UV and evaporative light scattering detectors (ELSD)
when detecting tocopherols and tocotrienols in olive oils (Cunha, Amaral, Fernandes, &
Oliveira, 2006). Nonetheless, UV and mass spectrometry (MS) are still widely applied in
vitamin E analysis.
1.3.5 Stability and degradation of vitamin E
The stability of naturally occurring forms of vitamin E as tocopherols is
considerably different from that of tocopheryl esters. Even though vitamin E is always
considered relatively more stable than other vitamins, unesterified tocopherol is considered
less stable because of the existence of its free phenolic hydroxyl group (Ottaway, 1993).
Vitamin E can be rapidly degraded after exposure to sunlight or artificial light with
wavelengths in the UV range (Ball, 2005). The atmospheric oxygen can also slowly induce
oxidation reactions to form quinone electrophiles which are biologically inactive
compounds (Ball, 2005; Cornwell & Ma, 2007). The oxidation can be accelerated in the
presence of heat, alkalinity, and some trace minerals such as iron, copper, zinc (BarreraArellano, Ruiz-M ndez, M rquez Ruiz, & Dobarganes, 1999; Dove & Ewan, 1991). In
general, the thermal stability of vitamin E in food depends on the food composition, heating
time, and heating method.
The esterified forms of a-tocopherol, such as a-TA and a-TS, offer longer shelf
life since they are resistant to oxidation after the esterification with introduction of an acetyl
group or succinate group at the C-6 position (Schneider, 2005). For example, light and air
have no destructive influence on the a-tocopherol acetate because it does not have the
reactive hydroxyl group (Ball, 2005). It was reported that a-tocopheryl acetate had shown
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a great stability during storage when it was added in wheat flour (Cort, Borenstein, Harley,
Osadca, & Scheimer, 1976).
1.4 Multivitamin/mineral Dietary Supplements
1.4.1 Stability and overage
Vitamin substances that exist either naturally or in concentrated commercial forms
can be unstable. Therefore, preparation of a relatively stable formulation involving these
materials is often very challenging. Many vitamins in the MVM are destructively affected
by the atmospheric oxygen, moisture, acids, or alkalis, and other vitamins or minerals
presented in the formulation. Oxidation due to contact with air or moisture in the air can
result in deterioration. Furthermore, the presence of minerals mixed with the vitamin
substances lead to deterioration probably due to catalytic action (Andersen, 1946). As the
FSVs are sensitive to different sources of factors such as temperature, light, and oxygen, it
is essential to add additional amounts of those active ingredients during the formulation
and manufacturing process in order to maintain the claimed concentration throughout the
commercial expiration period (LeDoux et al., 2015). The additional quantities of the active
ingredients to compensate for the loss during the long-term storage is recognized as
“overage,” which is determined based on the stability of that specific ingredient in the
product matrix. Moreover, different vitamins degrade at different rates associated with
various surrounding conditions. Therefore, the overage added will differ upon
characteristics of individual analyte. According to the report from trade associations from
the United States and the United Kingdom, typical levels of overages consistent with GMP
(good manufacturing practices) are 30-100% of label declaration for vitamin A, 30-50%
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for vitamin D2, 30% for vitamin D3, and 5% for vitamin E (Yetley, 2007). On the other
hand, since the FSVs can be stored and accumulated in lipid tissues of the body, excessive
intake may result in hypervitaminosis, which causes toxic symptoms. In this context, it is
desirable for manufacturers to minimize the dose overage to avoid consumption exceeding
the tolerable upper intake levels. Based on those circumstances, it is crucial to investigate
the degradation pattern of each individual FSV at various conditions in order to avoid
excessive fortification as well as maintain label claim requirement throughout the shelf life.
1.4.2 Sample extraction
Traditional extraction methods for FSVs in MVM involved sophisticated
procedures which are time consuming. Samples matrix such as MVMs, infant formulas
and animal feeds usually contain various components such as water-soluble vitamins,
excipients, minerals, and amino acids that have different biological and physicochemical
properties. Interferences from those ingredients might lead to low analytical precision and
accuracy, low recovery and lack of selectivity when being analyzed by HPLC (Wielinski
& Olszanowski, 1999). Saponification and the following up extraction of the vitamins from
the unsaponifiable fraction and direct liquid-liquid extraction are the most ordinarily used
methods for preparing food, pharmaceutical and nutraceutical samples for vitamin analysis.
Hot saponification is often carried out to release the bound and esterified forms of FSV,
dissolve gelatin and hydrolyze triglycerides when treating a sample that contains fats and
protein (Blake, 2007; Gentili & Caretti, 2011). However, saponification could not only
cause the oxidation of FSVs and false identity of vitamin A and E esters, but also generate
large analytical variation, low recovery and reproducibility, as well as long preparation
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time (Woollard, Bensch, Indyk, & McMahon, 2016). In order to overcome the
aforementioned problems, previous research stated that saponification can be implemented
at ambient temperature overnight to avoid thermal isomerization, along with addition of
antioxidants such as pyrogallol, butylated hydroxytoluene (BHT) or ascorbic acid (Perales,
Alegría, Barberá, & Farré, 2005). However, partial isomerization of vitamin D and
completely degradation of vitamin K can possibly happen when the saponification is
operated under the extremely high pH environment (Turner, King, & Mathiasson, 2001).
Alternatively, direct organic solvent extraction, such as liquid-liquid extraction, is
another commonly used method for extraction of FSVs from human fluids and
multivitamin samples, in light of the advantages of diversified solvents with a large
selectivity range of extraction options. A considerable number of solvents such as
acetonitrile, diethyl ether, methanol, tetrahydrofuran or their combinations have been used
for vitamin D extraction. In contrast, heptane, diethyl ether, and hexane are commonly used
for vitamin E extraction. For simultaneous extraction of vitamin A and E, the following
solvents that are often used include, but are not limited to, hexane, chloroform, and ethyl
acetate mixed with butanol. For example, in a research of FSV extraction from dietary
supplement tablets, the sample was at first suspended in a solvent mixture of
petroleum/ethyl acetate/methanol (1:1:1, v/v/v), and then the organic phase was transferred
and collected after the solid was precipitated (Breithaupt & Kraut, 2006). After several
repeated extraction processes, the collected solvent was evaporated and re-dissolved in
tert-butyl methyl ether (TBME)/methanol (1:1, v/v) solvent prior to the HPLC analysis
(Breithaupt & Kraut, 2006).
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Since the FSVs are unstable and easily oxidized, the vitamin supplements are
generally manufactured into beadlet form with a coating of either cornstarch with sucrose,
gelatin, or collagen (Xue, You, & He, 2008). This coating functions as a barrier against
moisture and oxygen to enhance the vitamin stability. Therefore, the beadlets coating needs
to be hydrolyzed or penetrated using solutions such as hydrochloride or sodium phosphate
tribasic, or proteinase to completely dissolve and release vitamins from the coating to
achieve full extraction (Qian & Sheng, 1998; Xue et al., 2008).
In recent decades, solid-phase extraction (SPE) strategy has been widely used to
separate and pre-concentrate targeted analytes from a complex sample matrix because it is
not only a rapid, effective, and versatile method, but also requires a much less amount of
organic solvent compared to the traditional liquid-liquid extraction. Moreover, the process
can remarkably minimize the contamination problem while improving the recovery yields
quantitatively. The SPE strategy typically involves four steps: conditioning, loading,
washing and elution. The sample matrix containing the targeted analytes is percolated
through the solid phase and absorbed onto the sorbent which can be composed of either
C18 or other types. Then an appropriate solvent mixture is used to wash the sorbent to
remove interfering impurities from the sample matrix. At last, another combination of
extraction solvent system is used to recover the retained analytes selectively during the
elution step.
1.4.3 HPLC analysis - simultaneous determination
Reliable and efficient analytical testing methods are always required to assess the
content uniformity of existing formulations for regulatory authorities and industries. In
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addition, precise labeling on dietary supplements and fortified foods prompt the
development of simultaneous determination methods for quantitative analysis of vitamins
(Nimalaratne, Sun, Wu, Curtis, & Schieber, 2014).
The AOAC International, the International Organization for Standardization (ISO)
and other organizations have published some approved methods for determination of
various FSVs, of which the analytical procedures normally involve the liquid
chromatography (LC), capillary electrophoresis (CE), spectrophotometric or gas
chromatography (GC) (Blake, 2007). Among those techniques, HPLC has been
significantly applied to the separation and quantitative and qualitative determination of
FSVs in various sources such as pharmaceutical formulations, biological fluids (Driskell,
Neese, Bryant, & Bashor, 1982), food samples (Salo-Väänänen et al., 2000), infant
formulas and animal feeds. Advantages of HPLC include, but are not limited to, its
sensitive, rapid and accurate analysis, solvent economy, and relatively small amount of
sample needed.
The HPLC is composed of different parts including stationary phase (columns),
mobile phase, pump, detector, and injector or autosampler. Along with the pressurized
liquid solvent, the sample mixture gets transferred through the column filled with various
types of adsorbent materials with the help of the pump. Various detectors, such as UV,
DAD, ELSD, and MS, identify each compound for the subsequent quantitative and
qualitative analysis (Abia, Mriziq, & Guiochon, 2009). Quantitative analysis of FSVs is
often accomplished by normal-phase and reverse-phase liquid chromatograph. Early
research show that silica normal-phase column is more stable against acids and alkaline
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conditions, and has a better separation for tocopherol isomers as well as cis- and transisomers of retinol (Ramadan & Mörsel, 2002; Salo-Väänänen et al., 2000). Furthermore, it
can provide better performance and stable resolution when being confronted with direct
injection of lipids (Chávez-Servín, Castellote, & López-Sabater, 2006; Ramadan & Mörsel,
2002). Nevertheless, reversed-phase column, especially the C18 column, is still the most
frequently used one in application because of its high efficiency, wide application and
improved column stability (Chatzimichalakis, Samanidou, & Papadoyannis, 2004).
In 1998, a method was developed and optimized for simultaneous determination of
all-trans vitamin A (retinol acetate), vitamin D3 (cholecalciferol), pro-vitamin D2
(ergosterol) and vitamin E (DL-a-tocopherol) in animal feeds using a RP-HPLC coupled
with UV detector (Qian & Sheng, 1998). A Novapak C18 column was used along with
methanol as the mobile phase. Another RP-HPLC method was developed for determination
of retinol, vitamin A palmitate, vitamin D, vitamin E alcohol, vitamin E acetate, and
vitamin K1 in dairy products, soy-based infant formulas, and milk. The separation was
achieved under a gradient elution using a binary mobile phase of methanol: ethyl acetate
(86:14) against acetonitrile on two connected 250 x 4.6 mm Zorbax ODS columns (Barnett,
Frick, & Baine, 1980). Another study described a method of simultaneous determination
of several water-soluble vitamins and fat-soluble vitamins including retinol palmitate,
cholecalciferol, a-tocopherol acetate in multi-vitamin pharmaceutical formulation
(Moreno & Salvado, 2000). The FSVs are sequentially eluted by methanol and chloroform
from SPE C18 sorbent after the elution of water-soluble vitamins. Then the analysis was
carried out on a RP C18 analytical column with a mobile phase composed of methanol:
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acetonitrile (95:5, v/v) at a flow rate of 2 ml/min in an isocratic mode (Moreno & Salvado,
2000). In 2004, a HPLC method coupled with a diode array detector (DAD) was developed
and optimized, by which the water-soluble and fat-soluble vitamins were separated in a
single run on a MetaChem Polaris C18-A column with a mobile phase composed of 0.01%
trifluoroacetic acid and methanol in an isocratic elution combined with linear gradient
mode (Klejdus et al., 2004). Another research compared the separation of the extracted alltrans-retinol and a-tocopherol from human serum on three C18 columns with different
particle sizes (3 µm and 5 µm) using a mobile phase of methanol-water (99:1, v/v) at 1.5
ml/min and 1 ml/min, respectively (Khan et al., 2010). The optimization process concluded
that the 3 µm columns offered shorter separation time, higher sensitivity and less solvent
consumption (Khan et al., 2010).
1.5 Objectives of the Project
The above methods reported in previous research involved different types of
matrices including biological samples, food and animal feed products, and pharmaceuticals,
which have raised big challenges to the analytical world. Since vitamins exist as either
vitamers with related structures or synthetic forms, highly efficient and valid method for
vitamin separation and accurate identification are needed (Nimalaratne et al., 2014).
However, only limited combinations of various forms of FSVs have been simultaneously
determined in MVM meaning that challenges still exist. For example, the vitamin E
succinate, which is commonly contained in dietary supplements, was not included in
previous methods for simultaneous detection. Moreover, different vitamins may have
concentrations that vary largely in the sample and some vitamins are likely to be interfered
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with other vitamins or minerals present in MVM dietary supplements or foodstuffs. In this
context, the objectives of this research are to
1)

develop and optimize an efficient and rapid method with high sensitivity and
resolution to extract and simultaneously detect FSVs including vitamin A esters,
vitamin E succinate, and vitamin D3 in MVM dietary supplements using HPLC
coupled with DAD detectors;

2)

investigate the degradation pattern of the above mentioned FSVs under various
influencing factors such as temperature, light, and pH;

3)

conduct stability study of vitamin A esters (acetate form and palmitate form) in the
MVM dietary supplements in different packages under different storage conditions
in order to evaluate the degradation rate, and compare the influencing degrees caused
by those conditions.
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Figure 1.1 Structures of retinol and retinyl esters
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Vitamin A palmitate (retinyl palmitate)

Vitamin A acetate (retinyl acetate)
Figure 1.2 UV absorption spectra of retinyl esters standards: (a) Vitamin A palmitate
(retinyl palmitate); (b) Vitamin A acetate (retinyl acetate)

26

C
A

D

B

Figure 1.3 Parent steroid nucleus

27

R
H

CH3

C

D
H

CH2

A
HO

VitaminDD2 2
Vitamine

R=

H

CH3

H 3C
H 3C

H

VitaminDD
Vitamine
3 3 R=

H

CH3

CH3

H 3C

CH3

Figure 1.4 Chemical structures of vitamin D2 and vitamin D3

28

350

300

300

250

250

200

200

mAu

mAu

264

350

150

100

100

50

50

204

0

367

150

200

0
250

300

350

nm

Figure 1.5 UV absorption spectra of vitamin D3

29

400

R1
HO
CH3
R2

O
R3

CH3

CH3
CH3

CH3

Tocopherols
R1
HO
CH3
R2

O
R3

CH3

CH3
CH3

CH3

Tocotrienols

R1

R2

R3

a-tocopherol / a-tocotrienol

5,7,8 - Trimethyl

CH3

CH3

CH3

b- tocopherol / b-tocotrienol

5,8 – Dimethyl

CH3

H

CH3

g- tocopherol / g-tocotrienol

7,8 – Dimethyl

H

CH3

CH3

d- tocopherol / d-tocotrienol

8 - Monomethyl

H

H

CH3

Figure 1.6 Eight forms of vitamin E

30

CH3

O
O
HO

CH3

O
H 3C

O
CH3

CH3

CH3

Figure 1.7 Chemical structure of d-a-tocopherol succinate

31

CH3
CH3

350

300

300

250

250

200

200

150

150

100

100

284

mAu

mAu

350

205

0

50

381

50

200

0
250

300

350

400

nm

Figure 1.8 UV absorption spectra of d-a-tocopheryl succinate

32

References
Abia, J. A., Mriziq, K. S., & Guiochon, G. A. (2009). Radial heterogeneity of some
analytical columns used in high-performance liquid chromatography. Journal of
Chromatography A, 1216(15), 3185-3191.
Aggarwal, B. B., Sundaram, C., Prasad, S., & Kannappan, R. (2010). Tocotrienols, the
vitamin E of the 21st century: its potential against cancer and other chronic
diseases. Biochemical Pharmacology, 80(11), 1613-1631.
Ahonen, M. H., Tenkanen, L., Teppo, L., Hakama, M., & Tuohimaa, P. (2000). Prostate
cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer
Causes & Control, 11(9), 847-852.
Andersen, C. N. (1946). Vitamin and mineral dietary supplement and method of making:
Google Patents.
Bakhtiyarova, S., Lesnyak, O., Kyznesova, N., Blankenstein, M., & Lips, P. (2006).
Vitamin D status among patients with hip fracture and elderly control subjects in
Yekaterinburg, Russia. Osteoporosis International, 17(3), 441-446.
Ball, G. F. M. (2005). Vitamins In Foods: Analysis, Bioavailability, and Stability: CRC
Press.
Barnett, S., Frick, L., & Baine, H. (1980). Simultaneous determination of vitamins A, D2
or D3, E and K1 in infant formulas and dairy products by reversed-phase liquid
chromatography. Analytical Chemistry, 52(4), 610-614.
Barrera Arellano, D., Ruiz Méndez, V., Márquez Ruiz, G., & Dobarganes, C. (1999).
Loss of tocopherols and formation of degradation compounds in triacylglycerol
model systems heated at high temperature. Journal of the Science of Food and
Agriculture, 79(13), 1923-1928.
Belsey, R., Deluca, H. F., & Potts Jr, J. T. (1971). Competitive binding assay for vitamin
D and 25-OH vitamin D. The Journal of Clinical Endocrinology & Metabolism,
33(3), 554-557.
Blake, C. J. (2007). Status of methodology for the determination of fat-soluble vitamins in
foods, dietary supplements, and vitamin premixes. Journal of AOAC International,
90(4), 897-910.
Blaner, W., & Olson, J. (1994). Retinol and retinoic acid metabolism eds.. The Retinoids:
Biology, Chemistry, and Medicine: 229-256. In S. MB, R. AB, & G. DS (Eds.),
The Retinoids: Biology, Chemistry, and Medicine (pp. 229-256). New York: Raven
Press.

33

Block, G. (1994). Nutrient sources of provitamin A carotenoids in the American diet.
American Journal of Epidemiology, 139(3), 290-293.
Breithaupt, D. E., & Kraut, S. (2006). Simultaneous determination of the vitamins A, E,
their esters and coenzyme Q10 in multivitamin dietary supplements using an RPC30 phase. European Food Research and Technology, 222(5-6), 643-649.
Brion, L. P., Bell, E. F., & Raghuveer, T. S. (2003). Vitamin E supplementation for
prevention of morbidity and mortality in preterm infants. Cochrane Database of
Systematic Reviews(3). doi:10.1002/14651858.CD003665
Broe, K. E., Chen, T. C., Weinberg, J., Bischoff Ferrari, H. A., Holick, M. F., & Kiel, D.
P. (2007). A higher dose of vitamin D reduces the risk of falls in nursing home
residents: a randomized, multiple dose study. Journal of the American Geriatrics
Society, 55(2), 234-239.
Burton, G. W., & Ingold, K. U. (1981). Autoxidation of biological molecules. 1.
Antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants
in vitro. Journal of the American Chemical Society, 103(21), 6472-6477.
Burton, G. W., & Traber, M. G. (1990). Vitamin E: antioxidant activity, biokinetics, and
bioavailability. Annual Review of Nutrition, 10(1), 357-382.
Byrdwell, W. C., DeVries, J., Exler, J., Harnly, J. M., Holden, J. M., Holick, M. F., Hollis,
B. W., Horst, R. L., Lada, M., & Lemar, L. E. (2008). Analyzing vitamin D in foods
and supplements: methodologic challenges. The American Journal of Clinical
Nutrition, 88(2), 554S-557S.
Chatzimichalakis, P. F., Samanidou, V. F., & Papadoyannis, I. N. (2004). Development of
a validated liquid chromatography method for the simultaneous determination of
eight fat-soluble vitamins in biological fluids after solid-phase extraction. Journal
of Chromatography B, 805(2), 289-296.
Chávez-Servín, J. L., Castellote, A. I., & López-Sabater, M. C. (2006). Simultaneous
analysis of Vitamins A and E in infant milk-based formulae by normal-phase highperformance liquid chromatography–diode array detection using a short narrowbore column. Journal of Chromatography A, 1122(1), 138-143.
Cheeseman, K. H., Holley, A. E., Kelly, F. J., Wasil, M., Hughes, L., & Burton, G. (1995).
Biokinetics in humans of RRR-α-tocopherol: the free phenol, acetate ester, and
succinate ester forms of vitamin E. Free Radical Biology and Medicine, 19(5), 591598.
Chen, T. C., Chimeh, F., Lu, Z., Mathieu, J., Person, K. S., Zhang, A., Kohn, N., Martinello,
S., Berkowitz, R., & Holick, M. F. (2007). Factors that influence the cutaneous

34

synthesis and dietary sources of vitamin D. Archives of Biochemistry and
Biophysics, 460(2), 213-217.
Christakos, S., Dhawan, P., Porta, A., Mady, L. J., & Seth, T. (2011). Vitamin D and
intestinal calcium absorption. Molecular and Cellular Endocrinology, 347(1), 2529.
Cornwell, D. G., & Ma, J. (2007). Studies in vitamin E: biochemistry and molecular
biology of tocopherol quinones. Vitamins & Hormones, 76, 99-134.
Cort, W., Borenstein, B., Harley, J., Osadca, M., & Scheimer, J. (1976). Nutrient stability
of fortified cereal products. Food Technology, 30, 52-62.
Cremin, F., & Power, P. (1985). Vitamins in bovine and human milks. In P. F. Fox (Ed.),
Developments in Dairy Chemistry—3 (pp. 337-398). London: Springer.
Cunha, S. C., Amaral, J. S., Fernandes, J. O., & Oliveira, M. B. P. (2006). Quantification
of tocopherols and tocotrienols in Portuguese olive oils using HPLC with three
different detection systems. Journal of Agricultural and Food Chemistry, 54(9),
3351-3356.
D’Ambrosio, D. N., Clugston, R. D., & Blaner, W. S. (2011). Vitamin A metabolism: an
update. Nutrients, 3(1), 63-103.
Dary, O., & Mora, J. O. (2002). Food fortification to reduce vitamin A deficiency:
International Vitamin A Consultative Group recommendations. The Journal of
Nutrition, 132(9), 2927S-2933S.
De Leenheer, A. P., De Bevere, V. O., De Ruyter, M. G., & Claeys, A. E. (1979).
Simultaneous determination of retinol and α-tocopherol in human serum by highperformance liquid chromatography. Journal of Chromatography B: Biomedical
Sciences and Applications, 162(3), 408-413.
Dove, C., & Ewan, R. (1991). Effect of trace minerals on the stability of vitamin E in swine
grower diets. Journal of Animal Science, 69(5), 1994-2000.
Driskell, W. J., Neese, J. W., Bryant, C. C., & Bashor, M. M. (1982). Measurement of
vitamin A and vitamin E in human serum by high-performance liquid
chromatography. Journal of Chromatography B: Biomedical Sciences and
Applications, 231(2), 439-444.
Earnest, C., Cooper, K. H., Marks, A., & Mitchell, T. L. (2002). Efficacy of a complex
multivitamin supplement. Nutrition, 18(9), 738-742.

35

Eitenmiller, R. R., & Landen, W. O. (2010). Vitamin analysis for the health and food
sciences: CRC Press.
Fellman, R. L., Dimick, P. S., & Hollender, R. (1991). Photooxidative stability of vitamin
A fortified 2% lowfat milk and skim milk. Journal of Food Protection, 54(2), 113116.
Feskanich, D., Singh, V., Willett, W. C., & Colditz, G. A. (2002). Vitamin A intake and
hip fractures among postmenopausal women. The Journal of the American Medical
Association, 287(1), 47-54.
Garland, C. F., Garland, F. C., Gorham, E. D., Lipkin, M., Newmark, H., Mohr, S. B., &
Holick, M. F. (2006). The role of vitamin D in cancer prevention. American Journal
of Public Health, 96(2), 252-261.
Gaylord, A., Warthesen, J., & Smith, D. (1986). Effect of fluorescent light on the
isomerization of retinyl palmitate in skim milk. Journal of Food Science, 51(6),
1456-1458.
Genestar, C., & Grases, F. (1995). Determination of vitamin A in pharmaceutical
preparations by high-performance liquid chromatography with diode-array
detection. Chromatographia, 40(3), 143-146.
Gentili, A., & Caretti, F. (2011). Evaluation of a method based on liquid chromatography–
diode array detector–tandem mass spectrometry for a rapid and comprehensive
characterization of the fat-soluble vitamin and carotenoid profile of selected plant
foods. Journal of Chromatography A, 1218(5), 684-697.
Grady, L., & Thakker, K. (1980). Stability of solid drugs: degradation of ergocalciferol
(vitamin D2) and cholecalciferol (vitamin D3) at high humidities and elevated
temperatures. Journal of Pharmaceutical Sciences, 69(9), 1099-1102.
Hakansson, B., Jagerstad, M., & Oste, R. (1987). Determination of vitamin -E in wheat
products by HPLC. Journal of Micronutrient Analysis, 3(4), 307-318.
Hanson, A. L., & Metzger, L. E. (2010). Evaluation of increased vitamin D fortification in
high-temperature, short-time–processed 2% milk, UHT-processed 2% fat chocolate
milk, and low-fat strawberry yogurt. Journal of Dairy Science, 93(2), 801-807.
Holick, M. F. (2006). Resurrection of vitamin D deficiency and rickets. The Journal of
Clinical Investigation, 116(8), 2062.
Holick, M. F. (2007). Vitamin D deficiency. The New England Journal of Medicine,
2007(357), 266-281.

36

Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A.,
Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011). Evaluation, treatment, and
prevention of vitamin D deficiency: an Endocrine Society clinical practice
guideline. The Journal of Clinical Endocrinology & Metabolism, 96(7), 1911-1930.
Holick, M. F., & Chen, T. C. (2008). Vitamin D deficiency: a worldwide problem with
health consequences. The American Journal of Clinical Nutrition, 87(4), 1080S1086S.
Institute of Medicine. (2001a). Dietary Reference Intakes for Vitamin A, Vitamin K,
Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum,
Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press.
Institute of Medicine. (2001b). Dietary Reference Intakes for Vitamin C, Vitamin E,
Selenium, and Carotenoids. Washington, DC: National Academy Press.
Israel, K., Yu, W., Sanders, B. G., & Kline, K. (2000). Vitamin E succinate induces
apoptosis in human prostate cancer cells: role for Fas in vitamin E succinatetriggered apoptosis. Nutrition and Cancer, 36(1), 90-100.
Jin, X., Yang, X., Yang, L., Liu, Z., & Zhang, F. (2004). Autoxidation of isotachysterol.
Tetrahedron, 60(12), 2881-2888.
Jones, G. (1978). Assay of vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in
human plasma by high-performance liquid chromatography. Clinical Chemistry,
24(2), 287-298.
Kazmi, S. A., Vieth, R., & Rousseau, D. (2007). Vitamin D3 fortification and quantification
in processed dairy products. International Dairy Journal, 17(7), 753-759.
Khan, A., Khan, M. I., Iqbal, Z., Shah, Y., Ahmad, L., & Watson, D. G. (2010). An
optimized and validated RP-HPLC/UV detection method for simultaneous
determination of all-trans-retinol (vitamin A) and α-tocopherol (vitamin E) in
human serum: comparison of different particulate reversed-phase HPLC columns.
Journal of Chromatography B, 878(25), 2339-2347.
Klejdus, B., Petrlová, J., Potěšil, D., Adam, V., Mikelová, R., Vacek, J., Kizek, R., &
Kubáň, V. (2004). Simultaneous determination of water-and fat-soluble vitamins
in pharmaceutical preparations by high-performance liquid chromatography
coupled with diode array detection. Analytica Chimica Acta, 520(1), 57-67.
Kline, K., Cochran, G. S., & Sanders, B. G. (1990). Growth inhibitory effects of vitamin
E succinate on retrovirus transformed tumor cells in vitro. Nutrition and Cancer,
14(1), 27-41.

37

Kowdley, K. V., Mason, J. B., Meydani, S. N., Cornwall, S., & Grand, R. J. (1992).
Vitamin E deficiency and impaired cellular immunity related to intestinal fat
malabsorption. Gastroenterology, 102(6), 2139-2142.
Kramer, J. K., Blais, L., Fouchard, R. C., Melnyk, R. A., & Kallury, K. M. (1997). A rapid
method for the determination of vitamin E forms in tissues and diet by highperformance liquid chromatography using a normal-phase diol column. Lipids,
32(3), 323-330.
Kurlandsky, S. B., Duell, E. A., Kang, S., Voorhees, J. J., & Fisher, G. J. (1996). Autoregulation of retinoic acid biosynthesis through regulation of retinol esterification
in human keratinocytes. Journal of Biological Chemistry, 271(26), 15346-15352.
Kurmann, A., & Indyk, H. (1994). The endogenous vitamin D content of bovine milk:
influence of season. Food Chemistry, 50(1), 75-81.
Lamberg-Allardt, C. (2006). Vitamin D in foods and as supplements. Progress in
Biophysics and Molecular Biology, 92(1), 33-38.
Larsen, E. R., Mosekilde, L., & Foldspang, A. (2004). Vitamin D and calcium
supplementation prevents osteoporotic fractures in elderly community dwelling
residents: a pragmatic population based 3 year intervention study. Journal of
Bone and Mineral Research, 19(3), 370-378.
LeDoux, M. A., Appelhans, K. R., Braun, L. A., Dziedziczak, D., Jennings, S., Liu, L.,
Osiecki, H., Wyszumiala, E., & Griffiths, J. C. (2015). A quality dietary
supplement: before you start and after it’s marketed—a conference report.
European Journal of Nutrition, 54(1), 1-8.
Lee, J., Ye, L., Landen, W. O., & Eitenmiller, R. R. (2000). Optimization of an extraction
procedure for the quantification of vitamin E in tomato and broccoli using response
surface methodology. Journal of Food Composition and Analysis, 13(1), 45-57.
Lee, J. H., O'Keefe, J. H., Bell, D., Hensrud, D. D., & Holick, M. F. (2008). Vitamin D
deficiency: an important, common, and easily treatable cardiovascular risk factor?
Journal of the American College of Cardiology, 52(24), 1949-1956.
Lips, P. (2006). Vitamin D physiology. Progress in Biophysics and Molecular Biology,
92(1), 4-8.
Marchetti, M., Ashmead, H. D., Tossani, N., Marchetti, S., & Ashmead, S. D. (2000).
Comparison of the rates of vitamin degradation when mixed with metal sulphates
or metal amino acid chelates. Journal of Food Composition and Analysis, 13(6),
875-884.

38

McGinnis, J. M., Birt, D. F., Brannon, P. M., Carroll, R. J., Gibbons, R. D., Hazzard, W.
R., Kamerow, D. B., Levin, B., Ntambi, J. M., & Paneth, N. (2006). National
Institutes
of
Health
State-of-the-Science
Conference
Statement:
multivitamin/mineral supplements and chronic disease prevention. Nutrition
Today, 41(5), 196-206.
Melhus, H., Michaelsson, K., Kindmark, A., Bergstrom, R., Holmberg, L., Mallmin, H.,
Wolk, A., & Ljunghall, S. (1998). Excessive dietary intake of vitamin A is
associated with reduced bone mineral density and increased risk for hip fracture.
Annals of Internal Medicine, 129(10), 770-778.
Moreno, P., & Salvado, V. (2000). Determination of eight water-and fat-soluble vitamins
in multi-vitamin pharmaceutical formulations by high-performance liquid
chromatography. Journal of Chromatography A, 870(1), 207-215.
Nair, P., Bucana, C., de Leon, S., & Turner, D. (1965). Gas chromatographic studies of
vitamins D2 and D3. Analytical Chemistry, 37(6), 631-636.
Nimalaratne, C., Sun, C., Wu, J., Curtis, J. M., & Schieber, A. (2014). Quantification of
selected fat soluble vitamins and carotenoids in infant formula and dietary
supplements using fast liquid chromatography coupled with tandem mass
spectrometry. Food Research International, 66, 69-77.
Nollet, L. M. L. (2004). Handbook of Food Analysis: Physical characterization and
nutrient analysis: Marcel Dekker.
O'Byrne, S. M., & Blaner, W. S. (2013). Retinol and retinyl esters: biochemistry and
physiology thematic review series: fat-soluble vitamins: vitamin A. Journal of
Lipid Research, 54(7), 1731-1743.
Olson, J. A. (1987). Recommended dietary intakes (RDI) of vitamin A in humans. The
American Journal of Clinical Nutrition, 45(4), 704-716.
Ottaway, P. B. (1993). The Technology of Vitamins in Food: Blackie Academic &
Professional.
Palczewski, K. (2012). Chemistry and biology of vision. Journal of Biological Chemistry,
287(3), 1612-1619.
Perales, S., Alegría, A., Barberá, R., & Farré, R. (2005). Determination of vitamin D in
dairy products by high performance liquid chromatography. Food Science and
Technology International, 11(6), 451-462.

39

Pittas, A. G., Lau, J., Hu, F. B., & Dawson-Hughes, B. (2007). The role of vitamin D and
calcium in type 2 diabetes. A systematic review and meta-analysis. The Journal of
Clinical Endocrinology & Metabolism, 92(6), 2017-2029.
Prasad, K. N., & Edwards-Prasad, J. (1982). Effects of tocopherol (vitamin E) acid
succinate on morphological alterations and growth inhibition in melanoma cells in
culture. Cancer Research, 42(2), 550-555.
Prasad, K. N., Kumar, B., Yan, X. D., Hanson, A. J., & Cole, W. C. (2003). α-tocopheryl
succinate, the most effective form of vitamin E for adjuvant cancer treatment: a
review. Journal of the American College of Nutrition, 22(2), 108-117.
Qian, H., & Sheng, M. (1998). Simultaneous determination of fat-soluble vitamins A, D
and E and pro-vitamin D2 in animal feeds by one-step extraction and highperformance liquid chromatography analysis. Journal of Chromatography A,
825(2), 127-133.
Radner, B. S., & Kennedy, A. R. (1986). Suppression of X-ray induced transformation by
vitamin E in mouse C3H/10T12 cells. Cancer Letters, 32(1), 25-32.
Rama, B. N., & Prasad, K. N. (1983). Study on the specificity of α-tocopheryl (vitamin E)
acid succinate effects on melanoma, glioma and neuroblastoma cells in culture.
Proceedings of the Society for Experimental Biology and Medicine, 174(2), 302307.
Ramadan, M., & Mörsel, J. T. (2002). Direct isocratic normal-phase HPLC assay of fatsoluble vitamins and b-carotene in oilseeds. European Food Research and
Technology, 214(6), 521-527.
Renken, S. A., & Warthesen, J. J. (1993). Vitamin D stability in milk. Journal of Food
Science, 58(3), 552-555.
Rucker, R. B., Zempleni, J., Suttie, J. W., & McCormick, D. B. (2007). Handbook of
Vitamins, Fourth Edition: CRC Press.
Salo-Väänänen, P., Ollilainen, V., Mattila, P., Lehikoinen, K., Salmela-Mölsä, E., &
Piironen, V. (2000). Simultaneous HPLC analysis of fat-soluble vitamins in
selected animal products after small-scale extraction. Food Chemistry, 71(4), 535543.
Schneider, C. (2005). Chemistry and biology of vitamin E. Molecular Nutrition & Food
Research, 49(1), 7-30.
Semo, E., Kesselman, E., Danino, D., & Livney, Y. D. (2007). Casein micelle as a natural
nano-capsular vehicle for nutraceuticals. Food Hydrocolloids, 21(5), 936-942.

40

Tang, B. M., Eslick, G. D., Nowson, C., Smith, C., & Bensoussan, A. (2007). Use of
calcium or calcium in combination with vitamin D supplementation to prevent
fractures and bone loss in people aged 50 years and older: a meta-analysis. The
Lancet, 370(9588), 657-666.
Trump, D. L., & Johnson, C. S. (2010). Vitamin D and cancer. New York: Springer Science
& Business Media.
Turley, J. M., Fu, T., Ruscetti, F. W., Mikovits, J. A., Bertolette, D. C., & BirchenallRoberts, M. C. (1997). Vitamin E succinate induces Fas-mediated apoptosis in
estrogen receptor-negative human breast cancer cells. Cancer Research, 57(5),
881-890.
Turley, J. M., Funakoshi, S., Ruscetti, F. W., Kasper, J., Murphy, W. J., Longo, D. L., &
Birchenall-Roberts, M. C. (1995). Growth inhibition and apoptosis of RL human B
lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming
growth factor B. Cell Growth and Differentiation, 6(6), 655-664.
Turner, C., King, J. W., & Mathiasson, L. (2001). Supercritical fluid extraction and
chromatography for fat-soluble vitamin analysis. Journal of Chromatography A,
936(1), 215-237.
Ueda, T., & Igarashi, O. (1990). Determination of vitamin E in biological specimens and
foods by HPLC-pretreatment of samples and extraction of tocopherols. Journal of
Micronutrient Analysis, 7(2), 79-96.
Upreti, P., Mistry, V., & Warthesen, J. (2002). Estimation and fortification of vitamin D3
in pasteurized process cheese. Journal of Dairy Science, 85(12), 3173-3181.
Van Breemen, R. B., Nikolic, D., Xu, X., Xiong, Y., Van Lieshout, M., West, C. E., &
Schilling, A. B. (1998). Development of a method for quantitation of retinol and
retinyl palmitate in human serum using high-performance liquid chromatography–
atmospheric pressure chemical ionization–mass spectrometry. Journal of
Chromatography A, 794(1), 245-251.
Visser, M., Deeg, D. J., & Lips, P. (2003). Low vitamin D and high parathyroid hormone
levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the
Longitudinal Aging Study Amsterdam. The Journal of Clinical Endocrinology &
Metabolism, 88(12), 5766-5772.
Vogel, S., Gamble, M., & Blaner, W. (1999). Retinoid uptake, metabolism and transport.
The Handbook of Experimental Pharmacology: Retinoids, 139, 31-95.
Wacker, M., & Holick, M. F. (2013). Vitamin D - effects on skeletal and extraskeletal
health and the need for supplementation. Nutrients, 5(1), 111-148.

41

Wagner, D., Rousseau, D., Sidhom, G., Pouliot, M., Audet, P., & Vieth, R. (2008). Vitamin
D3 fortification, quantification, and long-term stability in Cheddar and low-fat
cheeses. Journal of Agricultural and Food Chemistry, 56(17), 7964-7969.
Wang, X. D. (2005). Alcohol, vitamin A, and cancer. Alcohol, 35(3), 251-258.
Wielinski, S., & Olszanowski, A. (1999). Simultaneous determination of retinol acetate,
retinol palmitate, cholecalciferol, α-tocopherol acetate and alphacalcidol in
capsules by non-aqueous reversed-phase HPLC and column backflushing.
Chromatographia, 50(1), 109-112.
Woollard, D. C., Bensch, A., Indyk, H., & McMahon, A. (2016). Determination of vitamin
A and vitamin E esters in infant formulae and fortified milk powders by HPLC:
Use of internal standardisation. Food Chemistry, 197, 457-465.
Xue, X., You, J., & He, P. (2008). Simultaneous determination of five fat-soluble vitamins
in feed by high-performance liquid chromatography following solid-phase
extraction. Journal of Chromatographic Science, 46(4), 345-350.
Yetley, E. A. (2007). Multivitamin and multimineral dietary supplements: definitions,
characterization, bioavailability, and drug interactions. The American Journal of
Clinical Nutrition, 85(1), 269S-276S.
Yu, W., Israel, K., Liao, Q. Y., Aldaz, C. M., Sanders, B. G., & Kline, K. (1999). Vitamin
E succinate (VES) induces Fas sensitivity in human breast cancer cells. Cancer
Research, 59(4), 953-961.
Zhang, Y., Ni, J., Messing, E. M., Chang, E., Yang, C.-R., & Yeh, S. (2002). Vitamin E
succinate inhibits the function of androgen receptor and the expression of prostatespecific antigen in prostate cancer cells. Proceedings of the National Academy of
Sciences, 99(11), 7408-7413.

42

CHAPTER TWO
OPTIMIZATION OF EXTRACTION METHOD FOR SIMULTANEOUS
DETERMINATION OF FAT-SOLUBLE VITAMINS IN DIETARY SUPPLEMENTS
Abstract
This study aimed to optimize the factors influencing the extraction efficiency of
encapsulated fat-soluble vitamins (FSVs), including retinyl acetate, retinyl palmitate,
cholecalciferol, and d-a-tocopheryl acid succinate in multivitamins dietary supplements.
Those factors included the concentration of HCl solution, extraction temperature, and
extraction time. The response surface methodology (RSM) was employed to evaluate the
effects of those factors on the FSV extraction yields and to determine the optimal extraction
condition for maximum extraction yields. The results showed that higher intensities of
signals of the detected compounds were observed when the multivitamin/mineral tablets
(MVMs) were mixed with 0.4 N HCl solution at 50°C for 2 min, followed by a methanol
extraction and a subsequent non-polar solvent extraction, particularly by a mixture of
hexane:ethyl acetate (70:30, v/v). Besides, a method for simultaneous identification and
quantification of those four aforementioned FSVs using a HPLC coupled with diode array
detector (DAD) was developed and validated. Successful separation of the FSVs was
achieved within 25 minutes on a Poroshell 120 EC-C18 (4.6 x 100 mm, 2.7 µm) column,
using methanol:0.2% formic acid in water (97:3, v/v) as the mobile phase. Moreover,
extraction recoveries of the vitamin A esters (i.e., retinyl acetate and retinyl palmitate),
which spiked at three concentrations, were determined in a range from 92% to 106%, and
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those recoveries for the vitamin E succinate and vitamin D ranged from 78% to 90%.
Finally, the intra-day and inter-day tests were performed at three standard concentrations
to find the analytical precision. The results showed that the relative standard deviations
(RSDs) were below 7% for all of the four FSVs.
2.1 Introduction
Consumption of dietary supplements, especially the multivitamin/mineral (MVM)
supplements, has steadily increased over the past decades. Among those products, fatsoluble vitamins (FSVs), including the vitamin A, D, E and K, play important roles for
human health. However, excessive consumption of FSVs can be toxic, causing soft-tissue
calcification, bone resorption, inhibition of bone formation, and other chronic diseases
(Binkley & Krueger, 2000; Holmes & Kummerow, 1983). This finding suggests that
precise and accurate analysis of FSVs is necessary and indispensable for both the
regulatory agents and the pharmaceutical and nutraceutical industries so as to scrutinize
the level of FSVs in the formulas and to label the products properly.
During recent years, a variety of methods have been developed for analysis of FSVs
in different complex matrices, such as food, pharmaceutical preparations, and human fluids
(Table 2.1). Particularly, high performance liquid chromatography (HPLC) has offered a
convenient universal approach for this analysis due to its desirable selectivity, sensitivity,
precision, and efficiency. However, a few methods were developed for the simultaneous
determination of specific FSVs in different sample matrices. Among those limited
approaches, difficulties and challenges still exist due to several reasons. For example,
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complexity of the chemical composition of the MVM dietary supplements leads to higher
risks of analytical interferences (Nimalaratne, Sun, Wu, Curtis, & Schieber, 2014).
Moreover, due to the widely scattered biopotencies and the RDA (recommended daily
allowance) levels of different FSVs, the concentration of individual FSV in one sample
normally exists in a large variation (Moreno & Salvado, 2000). For example, vitamin D3
generally exists in small quantities in a sample whereas others can be found at a substantial
level. This quantitative inconsistency can easily cause a poor recovery during the chemical
extraction, as well as low sensitivity and selectivity during the HPLC analysis. In addition,
there is a big challenge for effective separation of diverse structurally related vitamers as
well as their synthetic forms. Particularly, it is noteworthy that d-a-tocopheryl acid
succinate (vitamin E succinate) is rarely mentioned in previous literatures. Instead, most of
the previous studies used tocopheryl acetate or tocopherol to develop the relevant analytical
methods (Thomas, Sharpless, Yen, & Immer, 2011). However, as an alternative form of
vitamin E, vitamin E succinate is gaining increased interest in industries and academia as
it has been confirmed in several studies for its health benefits in light of its high
effectiveness on adjuvant cancer treatment compared to the other forms of vitamin E
(Angulo-Molina, Reyes-Leyva, López-Malo, & Hernández, 2014; E. Lee et al., 2006).
Therefore, in this study, samples containing the vitamin E succinate as the only source for
vitamin E will be used in the development of simultaneous determination of the FSVs.
Extraction is another critical step in sample pretreatment prior to the chemical
determination. There is a big concern for the effective extraction of FSVs because those
vitamins might have been encapsulated in order to achieve a better stability in dietary
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supplements, which, on the other hand, will inhibit their sufficient extraction. Besides, due
to the heterogeneous distribution of the encapsulated particles in the products, the precision
of the analytical procedure can be negatively affected (Blake, 2007). In the meantime, as
new technologies are being developed, various materials have been adapted for
encapsulation, such as high melting-point triglycerides, gums, and proteins, have led to
greater complexity and more difficulties upon the extraction of FSVs (Blake, 2007).
Unfortunately, in available literature, steps to destroy the microencapsulation coating in
order to release the FSVs were rarely described in the sample preparation protocols.
Therefore, the aims of this study are to (1) optimize the procedures for the
extraction of FSVs in the MVM supplements containing encapsulated vitamin A acetate
(retinyl acetate), vitamin A palmitate (retinyl palmitate), vitamin D3 (cholecalciferol), and
vitamin E succinate (d-a-tocopheryl acid succinate), and (2) develop a reliable HPLCDAD method to simultaneously determine the aforementioned vitamin A, D and E.
2.2 Material and Methods
2.2.1. Chemicals and reagents
All the chemical standards, including retinyl acetate, retinyl palmitate,
cholecalciferol, and d-a-tocopheryl acid succinate, were purchased from Sigma-Aldrich
(Milwaukee, USA). Hydrochloric acid (37%) and formic acid (99%) for analysis were
obtained from Acros Organics (New Jersey, USA). Alcohol 200 Proof was purchased from
Decon Laboratories Inc (Pennsylvania, USA). HPLC-grade solvents including hexane,
methanol, ethyl acetate, chloroform, and dichloromethane were purchased from Fisher
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Scientific (Atlanta, GA, USA). Deionized water was obtained through a Milli-Q water
purification system (Millipore, Bedford, MA, USA). Multivitamin/multimineral tablets are
commercial dietary supplement products.
2.2.2. Chromatographic system
The HPLC-DAD system for the analysis of FSVs is composed of a CBM-20A
controller, a LC-20AT pump, a DGU-20As degasser, a SIL-20A HT auto-sampler, a SPDM20A diode array detector (DAD), and a CTO-20A column oven (Shimadzu USA
Manufacturing Inc, USA). The HPLC column used was a reversed-phase (RP) Poroshell
120 EC-C18 (4.6 x 100 mm, 2.7µm), which was purchased from Agilent Technologies
(Santa Clara, CA, USA) and kept at a constant temperature (35°C) during the analysis.
The mobile phase comprised of 0.2% formic acid in water (A) and methanol (B)
with a gradient elution that follows: in the range of 0-8 min, 3:97 (0.02% formic
acid:methanol); at 8.5 min, decreased to 0:100; at 24 min, increased back up to 3:97. The
flow rate was 1.0 mL/min and the injection volume was 20 µL.
2.2.3. Standard preparation
Stock solutions of the chemical standards of retinyl acetate, retinyl palmitate,
cholecalciferol, and d-a-tocopheryl acid succinate were prepared in the concentration of
2000 µg/mL, and stored at -20°C in different solvents including alcohol or hexane based
on their different chemical solubility.
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The working standards were freshly prepared by dilution of the concentrated stock
solutions and stored in dark amber vials. All four stock solutions were diluted into 500,
200, 100, 50, 25, 10, 5, and 1 µg/mL, respectively, for HPLC analysis to generate the
standard curves. Quantification was carried out by comparing the individual peak area of
the sample against that of the plotted working standards.
2.2.4. Preliminary study of extraction conditions
The aim of the preliminary study was to develop an appropriate procedure to extract
the FSVs from the MVM tablets. At first, the MVM tablets were ground into fine powders
using mortar and pestle. Second, the ground powder was accurately weighed on an
analytical balance and immediately transferred into a centrifuge tube covered with
aluminum foil so as to avoid oxidation of FSVs by light. It is worthy of mention that it is
important to either use low-actinic glassware or to cover the glassware with foil during the
entire extraction procedure. Then, 10 mL of HCl solution was added into the centrifuge
tube, followed by a vigorous mixing in a vortex mixer. Third, 10 mL of methanol were
added into the mixture in the tube and mixed for 10 min on a rotary mixer. Fourth, 20 mL
of hexane were added and mixed for 30 min to separate and extract the FSVs. Finally, the
mixture was centrifuged at 3000 rpm under darkness at 4°C for 10 min. After the
supernatant was transferred into a new amber vial, it was dried by purging with nitrogen
gas and reconstituted with ethanol. The sample was then filtered through 0.22 µm nylon
membrane prior to the HPLC analysis. Concentrations of the vitamin A acetate, vitamin A
palmitate, vitamin D3 and vitamin E succinate were determined based on their respective
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calibration curves. All assays corresponding to the preliminary study and the following
experiments were performed in triplicate.
2.2.5. Optimization of the extraction procedure for FSVs
In order to investigate the effects of the primary factors, including the concentration
of HCl solution, the time of the acidic hydrolysis of the encapsulation coatings, the
hydrolysis temperature, and the subsequent extraction solvent, on their efficiency of
extracting FSVs from the MVM samples, those factors mentioned above were respectively
studied while fixing other parameters in their respective tests.
2.2.5.1. Effect of concentration of HCl solution on extraction efficiency
The HCl solutions in four different concentrations (i.e, 0.1, 0.4, 0.7, and 1.0 N)
were respectively prepared, and heated to 80°C before they were added to the
aforementioned powdered MVM samples. The mixture was vigorously shaken for 2
minutes. The other extraction conditions were as same as those described above in the
preliminary study. Hexane was used as the extraction solvent.
2.2.5.2. Effect of hydrolysis time on extraction efficiency
The HCl solution in 0.4 N was heated to 80°C, and added to the ground samples,
which were immediately mixed on a vortex mixer for different times: 1, 2, 4, 6, and 8
minutes for comparison. The other extraction procedures were the same as those described
above.
2.2.5.3. Effect of temperature on extraction efficiency
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The HCl solutions in 0.4 N were heated to four different temperatures at 50°C,
65°C, 80°C, and 95°C, and respectively added to the ground samples. The samples were
immediately mixed on a vortex mixer for 2 minutes. The other extraction procedures were
the same as those described above.
2.2.5.4. Effect of extraction solvent on extraction efficiency
The HCl solution in 0.4 N was heated to 80°C and added to the ground samples.
The sample was immediately mixed by a vortex mixer for 2 minutes. After methanol was
added, the mixture was shaken for 10 minutes on a rotary mixer. Then, different extraction
solvents, including hexane, petroleum ether, ethyl acetate, chloroform, ethanol, and
methylene chloride, were respectively added into the mixtures to extract the FSVs. The
other extraction procedures were the same as those described above.
2.2.5.5. Response surface methodology (RSM) for optimization of extraction parameters
Response surface methodology (RSM) is an important and useful technique for
developing and optimizing processes in which the responses are influenced by multiple
variables (Baş & Boyacı, 2007). Based on the results obtained from the single-factor
experiments mentioned above, three levels of each parameter (i.e. HCl concentration,
hydrolysis time, hydrolysis temperature) that was involved in the extraction tests was
determined for RSM. A three-factor three-level Box–Behnken experimental design, which
consisted of a total number of seventeen experimental runs in randomized order including
five replicates of the center point, was used to determine the optimized combination of
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FSVs extraction variables. The experimental data obtained were fitted to a second-order
polynomial model used in the RSM, as shown in the following:
#

! = b! + $ b" %" +
"$%

#

#

$ b"" %"&
"$%

+ $ $ &"' %" %'

(1)

"('$%

where ! is the extraction yield of the FSV (i.e. the corresponding peak area of each FSV
at its maximum absorbance wavelength). &! , &" , &"" , and &"' are the regression coefficients
of the intercept, linear, quadratic and interaction, respectively. %" and %' are the
independent variables. The designed variables in this work were the hydrolysis time of the
HCl solution (%% ), concentration of the HCl solution (%& ), and the hydrolysis temperature
(%# ). The JMP software was used to generate the response surface plots and estimate the
coefficients of the second-order polynomial model.
2.2.6. Validation of the HPLC method
The HPLC method developed in this study was estimated in regards of its detective
linearity, accuracy, precision, limit of detection (LOD) and limit of quantification (LOQ).
The instrumental detective linearity for each of the aforementioned FSVs was evaluated by
a series of the mixed FSVs within their entire working range. Regarding the analytical
precision, the intra-day (n=6) test and inter-day (n=5) test for five consecutive days were
evaluated on three different concentrations of each of the examined FSVs. The intra-day
precision was calculated based on the six measurements that were conducted consecutively
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within a single day, while the inter-day precision was measured based on the five
measurements that were performed once a day during five consecutive days (Ermer &
Miller, 2005). Accuracy was evaluated by the recovery studies. The recovery was
determined by the following equation
Recovery % =

C)*+,-. − C/0)*+,-.
× 100
C1..-.

(2)

where Cspiked is the concentration of the analyte found in spiked sample, Cunspiked is
the concentration of the analyte measured in its original sample, and Cadded is the
concentration of the analyte added to the MVM sample. In addition, LOD and LOQ of each
vitamin were calculated based on the calibration lines established by six concentrations of
the vitamin standards. The following equations were used to determine the LOD and LOQ.
LOD =

3.3 ∗ 345
36789

(3)

LOQ =

10 ∗ 345
36789

(4)

where std stands for the standard deviation of the response of each FSVs, while slope is
the slope of the corresponding FSV calibration curve.
2.2.7 Statistical analysis
All experiment tests were conducted in triplicate. The results were presented as
mean ± standard deviation (SD). Statistical analysis was based on a response surface
methodology (RSM) to determine the importance of hydrolysis temperature, hydrolysis
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time, and concentration of HCl solution. Differences between treatments were determined
by ANOVA followed Tukey’s test. All statistical calculations were performed using JMP
13.0 (Cary, NC). Probability values less than 0.05 were considered evidences of statistical
significance.
2.3 Results and Discussion
2.3.1. Separation and identification of FSVs by HPLC-DAD
To develop a reliable HPLC method for a successful separation of the FSVs, a
solution of mixed standards composed of vitamin A acetate, vitamin A palmitate, vitamin
D3, and vitamin E succinate was prepared prior to the analysis. In addition, according to
previous literature, methanol with a small portion of water was often used as the mobile
phase for the separation of the aforementioned vitamins, except for vitamin E succinate.
Moreover, previous research showed that the strong carboxylic group in the vitamin E
succinate could forestall the separation of other polar vitamins such as retinyl palmitate,
and cause a fronting peak (Breithaupt & Kraut, 2006). In this context, in order to overcome
the problem and establish an optimal separation of all of the four FSVs, 0.2% formic acid
was added to the mobile phase A (water) and tested with a gradient elution. In addition to
this method, different ratios of the components (i.e., methanol and acidified water) in the
mobile phase, ranging from 90:10 to 98:2, were evaluated. Since it was found that a higher
percentage of methanol in the mobile phase led to an overlap of vitamin D3 and vitamin E
succinate, and its lower ratio significantly increased the retention time and led to smaller

53

peak area, the ratio of methanol to acidified water was finally adjusted to 97:3 because it
gave the best separation without the aforementioned problems.
Several previous studies used acetonitrile instead of methanol as the base of the
mobile phase (Barba, Esteve, & Frígola, 2011; Granado-Lorencio, Herrero-Barbudo,
Blanco-Navarro, & Pérez-Sacristán, 2010). However, it was found that acetonitrile usually
resulted in lower recoveries of the analytes than methanol or methanol-based solvents
(Gimeno et al., 2000). For example, it was observed that methanol provided a higher
recovery of vitamin E than acetonitrile (Lee, Chua, Ong, & Ong, 1992). This current study
also confirmed that, compared to the acetonitrile-based mobile phase, the methanol-based
mobile phase had exhibited a better performance concerning the retention time and peak
areas of the analytes. On the other hand, increasing the column temperature from room
temperature to 35°C was found to be able to shorten the peak retention time and improve
the peak shape. Figure 2.1 depicts the chromatogram of a solution with mixed standards,
which were separated by a mobile phase composed of methanol:0.2% formic acid in water
(97:3, v/v) in a gradient elution at temperature of 35°C and detected at 285 nm wavelength.
The gradient elution started at 97:3 and maintained in the first 7.5 min, then increased to
100% methanol during the next minute, maintained for the next 15 min, and finally
decreased back to 97:3. The flow rate was 1.0 mL/min.
2.3.2. Sample Treatment
Determination of FSVs by the official methods seems to be obsolete, timeconsuming, and laborious. In addition, current AOAC methods need updating, especially
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to accommodate ingredients made with novel encapsulation materials as well as modern
encapsulation techniques (Blake, 2007). In this context, new official methods for the
simultaneous determination of FSVs in dietary supplements or vitamin premixes need to
be established.
Extraction of FSVs can be performed by direct solvent extraction or by
saponification, a more severe treatment, although the former is preferred on account of
cost, time, and ability to avoid artifacts formation (Gentili & Caretti, 2011; Rizzolo &
Polesello, 1992). During the preliminary study mentioned in the Section 2.2.4, it was found
that the MVM sample was insoluble and easily precipitated if directly mixed with water or
organic solvents, even under the sonication. This situation prevented the encapsulated
FSVs from being released and dissolved in the organic solvents, although, in a previous
study regarding the extraction of FSVs from cereals, hot water (80°C) and sonication were
found to be effective in extracting vitamin E acetate and starch- or gelatin-encapsulated
vitamin A palmitate (Ye, Landen, & Eitenmiller, 2000). Since novel encapsulating
materials and encapsulation techniques have been developed in the last several decades,
and MVM supplements have become more complicated, methods that can effectively break
down the encapsulation coating to effectively release the encapsulated FSVs has become
more difficult and challenging.
Nevertheless, inspired by the aforementioned method which used hot water (80°C)
to remove the encapsulation coating, the D.I. water (80°C) was compared to an acidified
water in regards of their efficacy in extracting the FSVs from the MVM samples, in which
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each FSV was prepared to be equivalent to approximately 200 µg/mL. In this study, HCl
solutions in two different concentrations (i.e., 0.1 N and 1.0 N of HCl) and deionized water
were heated to 80°C, and then respectively added to the MVM powders to compare their
effectiveness in extracting FSVs. One sample was mixed with the 0.1 N HCl solution for
2 minutes, while its counterparts were mixed only with hot water (80°C) for different times
(2 min, 4 min, 6 min, and 8 min). At the same time, the sample treated with 1.0 N HCl
solution for 2 min was considered the control group in comparison with other
aforementioned treatments. As results shown in Table 2.2, the extracted and detected
amounts of the two vitamin A esters (i.e., vitamin A acetate and vitamin A palmitate) and
the vitamin D3 in the samples treated with hot water were all significantly lower than 31%
of their corresponding values in the control. In comparison, their detected amounts
extracted from the samples that were treated by 0.1 N HCl solution for 2 min were found
to be 70.6%, 64.9% and 93.4% of that of the control, which were significantly higher than
their counterparts treated by hot water. Moreover, vitamin E succinate has shown a
different scenario. There was no significant difference between the extraction yields of the
two HCl solution (1.0 N vs 0.1 N) treatments and the hot water treatments by 2 min and 4
min. However, the results also indicated that the extended time for hot water extraction
significantly decreased the extraction efficiency. The longer the extraction treatment by hot
water, the lower the extraction yield. Therefore, the HCl solution was confirmed to be more
desirable and more effective than water to break down the encapsulation coating to release
the FSVs.
2.3.3. Optimization of the procedure for FSVs extraction
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After the wall materials of the encapsulated FSV were hydrolyzed by the heated
HCl solution, the released FSVs could be exposed to a severe condition if high temperature
or excessive HCl solution was present, due to the fact that degradation of the FSVs might
have occurred (Lešková et al., 2006). Therefore, the factors including the HCl
concentration, hydrolysis time, as well as the hydrolysis temperature should be further
evaluated in regards of their effects on the FSVs extraction, which are discussed in the
following sections.
2.3.3.1. Effect of HCl concentration
HCl solutions in four concentrations (i.e., 0.1, 0.4, 0.7, and 1.0 N) were heated to
80°C and respectively added to the MVM samples as mentioned in the Section 2.3.2
Sample Treatment. Then the samples were vigorously mixed by a vortex mixer for two
minutes before the FSVs in the samples were extracted and determined by the HPLC-DAD.
As shown in Figure 2.2, the two treatments, including the 0.4 N and 0.7 N of the HCl
solutions, led to significantly higher extraction efficiency than the other two treatments
(i.e., 0.1 N and 1.0 N) for the extraction of all four FSVs from the MVM samples. In
addition, 0.4 N HCl solution exhibited the highest extraction efficacy for both vitamin A
acetate and vitamin E succinate (p<0.05). Based on the above-mentioned results, 0.4 N
HCl solution was selected to be the center point (coded as 0) for the subsequent RSM
experiments due to its high efficiency in extracting the FSVs from the MVM samples.
2.3.3.2. Effect of HCl hydrolysis time
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In order to hydrolyze the encapsulation coating materials of the MVM tablets so as
to effectively release the FSVs, and avoid their degradation at the same time, the hydrolysis
(mixing) time of HCl was evaluated. Results in Figure 2.3 demonstrated that, for vitamin
A acetate, vitamin A palmitate and vitamin D3, the samples treated by 0.4 N HCL for 2
min had significantly higher extraction yields than other treatments with a longer period of
hydrolysis time (p<0.05) based on the Tukey’s test. This phenomenon was explained by
the fact that the released FSVs were exposed to the acidic condition after the acidic
hydrolysis, which had expedited their degradation after a long exposure time. For vitamin
D3 and vitamin E succinate, there were no significant differences in their respective
extraction yields between their extraction treatment (time) of 1 min and 2 min. However,
for the other two vitamin A esters, 2 min hydrolysis provided significantly higher results
than the 1 min hydrolysis (p<0.05). But as mentioned above, extended extraction time,
such as 4 ,6, and 8 min, could remarkably decreased the yields. Therefore, 2 minutes was
optimal in allowing the MVM sample and HCl solution to be mixed in order to facilitate
the hydrolysis of the encapsulation material; and, in a large extent, to prevent the
degradation of the released FSVs. In this context, 2 minutes was determined to be the
optimal condition of the HCl hydrolysis time for the subsequent RSM experiments.
2.3.3.3. Effect of HCl temperature
Similar to the hydrolysis time and the concentration of HCl solution, the hydrolysis
temperature also had an effect on the extraction efficiency. Figure 2.4 showed different
profiles of the hydrolysis temperatures (i.e., 50, 60, 80 and 95°C) on the extraction of four
FSVs from the MVM samples. In regards to the vitamin A acetate, it could be most
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effectively extracted by the 0.4 N HCl solution at 80°C, resulting in significantly higher
extraction yield than other temperatures (p<0.05). In comparison, the temperature of the
same HCl solution at 50°C on hydrolysis of vitamin A palmitate’s encapsulation agent was
demonstrated to be more effective than other temperatures. For the vitamin D3, there were
no significant differences in their respective extraction yields between the hydrolysis
temperatures at 50°C, 65°C and 80°C, but they had significantly higher yields than their
counterparts at 95°C (p<0.05). For the vitamin E succinate, no significant difference was
observed between the four treatments. On the other hand, one previous study developed a
method which involved 0.05 M HCl to dissolve the multivitamin tablet at 60 ± 5°C
(Kozlov, Solunina, Lyubareva, & Nadtochii, 2003), and another study reported that the
sample mixture was mixed with an EDTA solution and kept in a 45°C water bath for 1
hour to dissolve the encapsulation gel (Phinney et al., 2011). Therefore, based on our
results and previous studies, temperature of the HCl solution at 50 °C was the desirable
extraction temperature since no significant differences were observed between the yields
of FSVs extracted by different temperatures within 50 to 80°C, except for the vitamin A
acetate and vitamin A palmitate mentioned early in this section. Considering the
requirement to simultaneously extract FSVs from the MVM samples, 50°C was selected
to be the center point for the subsequent RSM experiments.
2.3.3.4. Effect of extraction solvent
Previous literature has implied that extraction solvents could be the most crucial
factor to impact the extraction of FSVs from feed samples, particularly for vitamin A (Qian
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& Sheng, 1998). In most of the published methods, hexane has been used as the most
common extraction solvent for FSVs in regards to its relatively low cost, high safety and
low toxicity (Chauveau-Duriot, Doreau, Noziere, & Graulet, 2010; Gentili et al., 2012;
Woollard, Bensch, Indyk, & McMahon, 2016). Other alternative extraction solvents
included petroleum ether, ethyl acetate, chloroform, and acetone. For instance, in a
previous study, a solvent mixture of hexane:ethyl acetate (9:1 v/v) was used for extraction
of FSVs from dietary supplements (Nimalaratne et al., 2014), and another solvent mixture
of acetone:chloroform (3:7, v/v) was used for the extraction of FSVs from animal feeds
(Qian & Sheng, 1998). In the present study, several combinations of the organic solvents
were prepared in order to compare their efficacy on the extraction of the aforementioned
four FSVs. The results are shown in Table 2.3. Regardless of the high popularity of hexane
in many other relevant studies, this study showed that hexane had relatively lower
extraction efficacy, which provided the extraction yields of 46.34, 51.87, 43.75, and 42.65
µg/mL for the vitamin A acetate, vitamin A palmitate, vitamin D3 and vitamin E succinate,
respectively, from the MVM samples. In comparison, the solvent mixture of hexane:ethyl
acetate (70:30, v/v) was able to extract 96.70, 95.90, 87.2, and 84.70 µg/mL of the
corresponding FSVs. Besides, the same solvent mixture of hexane-ethyl acetate in another
ratio (i.e., 90:10, v/v) also showed significantly better extraction yields than hexane
(p<0.05).
In addition, chloroform was found to be the major cause for some undesirable
phenomena, such as incomplete centrifugation and cloudy mixture during the extraction,
which were attributed to chloroform’s high specific gravity (Qian & Sheng, 1998).
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Therefore, the solvent chloroform was only considered as a co-solvent in solvent
combinations in this study. As a result, the amount of vitamin A acetate extracted by the
solvent mixture of hexane:chloroform (50:50, v/v) was determined to be 55.92 µg/mL,
which was significantly lower than those extracted by the mixture of hexane:ethyl acetate
(either 70:30 or 90:10, v/v) (i.e. 96.70 and 78.65 µg/mL, respectively). Also, there was no
significant difference between the amounts extracted by the hexane:chloroform (50:50,
v/v) and hexane (46.34 µg/mL). The same scenarios were observed for the vitamin A
palmitate, vitamin D3 and vitamin E succinate, indicating that chloroform was less effective
than ethyl acetate to synergize the extraction efficiency of FSV with hexane. Moreover, the
combination of petroleum ether:chloroform:ethanol (60:35:5, v/v/v) only extracted 65.01,
72.07, 70.51, and 75.68

µg/mL of the four FSVs from the samples, which were

significantly lower than those extracted by the hexane:ethyl acetate (70:30, v/v) (i.e. 96.70,
95.90, 87.21, and 84.70 µg/mL) (see Table 2.3).
A previous study reported the application of another solvent mixture, petroleum
ether:ethyl acetate:methanol (1:1:1), which was adopted to be directly added to the ground
multivitamin tablets under the sonication for 30 seconds to extract vitamin A, E, and their
esters (Breithaupt & Kraut, 2006). Since methanol has already been added into my samples
during the sample preparation, mixtures of petroleum-ethyl acetate in two different
proportions (50:50 and 90:10, v/v) were evaluated. As a result, after the extraction by the
aforementioned two mixtures of petroleum-ethyl acetate, the yields of vitamin A palmitate
were 46.06 and 54.25 µg/mL, respectively, which were significantly (p<0.05) lower than
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those associated with the hexane-ethyl acetate combination (95.90 µg/mL for 70:30 v/v,
and 79.79 µg/mL for 90:10 v/v). The other three FSVs were observed with similar
situations as vitamin A palmitate (see Table 2.3).
In summary, among all the solvent mixture combinations that were tested, the
mixture hexane:ethyl acetate (70:30, v/v) has shown the best extraction efficacy, which has
extracted significantly higher amounts of vitamin A acetate and vitamin D3 from the
samples than other solvent mixtures (p<0.05). Although no significant difference was
observed between the amounts of vitamin A palmitate extracted by the mixtures of hexaneethyl acetate in its two combination ratios: 70:30 and 90:10, the former mixture has resulted
in significantly higher amounts of the extracted FSVs from the samples than all other
solvent mixtures (p<0.05) (see Table 2.3). Therefore, the solvent mixture of hexane:ethyl
acetate (70:30, v/v) was the best solvent to extract the FSVs from our MVM samples.
Following the solvent extraction, the supernatants were collected and evaporated
by mild nitrogen purging. Then, the residuals were subsequently reconstituted in methanolbased solution depending on the mobile phase used (Nimalaratne et al., 2014). However,
in my practice, it was found that the yield was much higher if the residual was reconstituted
in ethanol than in methanol (e.g. 87 µg/mL in ethanol vs. 68 µg/mL in methanol for the
vitamin E succinate in the same sample). Therefore, ethanol, rather than methanol, was
selected to redissolve the residual after the supernatant was evaporated under nitrogen.
2.3.3.5. RSM for optimization
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Based on the results obtained mentioned above, three levels for each extraction
variables were coded as -1, 0, 1 (see Table 2.4) for the RSM experiments. Each of the
experimental run was performed in triplicate. Table 2.4 lists the actual yields of FSVs
extracted from the MVM samples and the predicted yields calculated from the secondorder polynomial equation (Equation (1)), where Y represents the extraction yield (peak
area of each FSV detected at its corresponding optimal wavelength), and %% , %& , %#
represent the coded variables for the hydrolysis time, HCl concentration, and hydrolysis
temperature, respectively. To predict the extraction yield (!22 , !23 , !4 , and !5 ) of vitamin
A acetate, vitamin A palmitate, vitamin D3, vitamin E succinate, respectively, the fitted
models were expressed by the following equations:
!22 = 6.37 × 106 + 7.06 × 106 %% + 4.91 × 107 %&
+ 1.23 × 106 %# − 3.06 × 106 %%& − 6.43 × 107 %&&
− 0.12 × 108 %#& − 8.00 × 106 %% %&
+ 0.14 × 106 %% %# + 3.06 × 106 %& %#

(5)

!23 = −1.46 × 109 + 0.79 × 109 %% + 0.86 × 109 %&
+ 0.71 × 107 %# − 1.12 × 107 %%& − 8.69 × 107 %&&
− 0.58 × 108 %#& − 3.96 × 108 %% %#

(6)

!4 = −1.53 × 109 + 5.58 × 107 %% + 6.36 × 106 %&
+ 6.02 × 106 %# − 1.17 × 107 %%& − 7.71 × 107 %&&
− 0.60 × 108 %#& + 8.94 × 106 %% %&
− 0.17 × 106 %% %# + 1.00 × 106 %& %#

(7)

!5 = −1.88 × 107 + 1.01 × 107 %% + 3.28 × 106 %&
+ 0.59 × 106 %# − 2.40 × 106 %%& − 1.36 × 107 %&&
− 0.64 × 10# %#& + 0.20 × 106 %& %#

(8)
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The p-value of analysis of variance (ANOVA) for each model was found to be less
than 0.05 for all the four FSVs (shown Table 2.5 - 2.8), meaning that all the four regression
models were significantly affected by their independent variables. In addition, the ANOVA
analysis showed that the coefficients of determination (R2) were calculated in the range of
0.9626 - 0.9962, indicating that the models explained more than 96.26% of the variation
of FSVs’ yield. The p-values of Lack of Fit of the models were 0.0633, 0.5809, 0.4456,
0.0811 for the vitamin A acetate, vitamin A palmitate, vitamin D3 and vitamin E succinate,
respectively, which were larger than the significant level of 0.05. This implies that all the
models have adequately fit the data in the experimental design (Silva, Rogez, & Larondelle,
2007). In order to investigate the effects of the aforementioned three factors (independent
variables) (i.e. hydrolysis time, HCl concentration and temperature) on the extraction yield
of each FSV, the significance of each coefficient of those independent variables, as well as
their quadratic terms and their interactions, was estimated by checking their respective pvalues. As shown in the Table 2.5-2.8, the coefficients of the linear effects (%% , %& , and
%# ) and the quadratic effects (%%& , %&& , and %#& ) were found to be significant in all the models
for the four FSVs (p<0.05). The interaction terms (%% %& , %% %# , and %& %# ) were significant
in both the vitamin A acetate and vitamin D3 models (p<0.05) (Table 2.5 & 2.7). However,
the interaction terms (%% %& and %& %# ) for vitamin A palmitate, and (%% %& and %% %# ) for
vitamin E succinate were not significant due to their p-value larger than 0.05 (Table 2.6 &
2.8). Therefore, those non-significant interaction terms were excluded from their second
order polynomial models (Equation (6) and (8), respectively).
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The three-dimensional (3D) response surface plots were generated for each of the
four FSVs, which are profiled in Figure 2.5 - 2.8 using the JMP in order to illustrate the
relationship between the independent and dependent variables. In addition, when the twodimensional display (contour plot) of the surface plot displays ellipses or circles, the center
of the ellipses or circles refers to the maximum response point (Baş & Boyacı, 2007). For
example, in Figure 2.6, the following parameters, including 2.68 min of the hydrolysis
time, 0.53 N of the HCl concentration, and 51.89°C of the hydrolysis temperature, were
found to be the optimized parameters to achieve the highest extraction yield of vitamin A
palmitate. Similarly, an optimal condition for the extraction of vitamin A acetate was
determined to be 2.11 min, 0.40 N, and 65.00°C for the hydrolysis time, HCl concentration,
and temperature, respectively, using the surface plots and contour plots (Figure 2.5). In
regards to the vitamin D3 and vitamin E succinate, their optimal conditions were found to
be 2.19 min, 0.50 N, 51.08°C and 2.09 min, 0.52 N, 53.86°C, respectively (Figure 2.7 and
Figure 2.8).
In this context, 2.0 min (in the range of 2.11-2.68 min) of the hydrolysis time, 0.4
N of the HCl solution (in the range of 0.40-0.53 N) at 50.0°C was determined to be the
optimal condition for maximizing the simultaneous extraction yields of FSVs, while
preventing the degradation of the FSVs due to heat and strong acid during the extraction.
In order to validate the equation of the RSM model, five experiments were conducted under
the aforementioned optimal condition. The mean actual values (in 106) were 6.23±0.04,
15.96±0.52, 6.19±0.10, and 0.83±0.02 for the vitamin A acetate, vitamin A palmitate,
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vitamin D3 and vitamin E succinate, respectively. The results were in good agreement with
the predict values for each FSV, indicating that the proposed RSM model was accurate for
the FSVs extraction.
2.3.4. Method Validation
Standard solutions containing the four FSVs were analyzed, based on the method
described in the Section 2.3.1, to generate their respective calibration curves that were used
for the subsequent quantification. The calibration curves were respectively plotted by the
concentration against the peak area of each vitamin. The calibration curves of the four
FSVs exhibited excellent linearity ranging from 0.9986 to 0.9999 within their linear ranges,
from 1.25 to 400 µg/mL for vitamin A acetate and vitamin A palmitate, 6.25 to 400 µg/mL
for Vitamin D3, and 12.5-400 µg/mL for vitamin E succinate (Tablet 2.8).
The LOD and LOQ were also determined based on the calibration curves of each
FSV using the equations mentioned earlier (see Section 2.2.6). In consequence, the LOD
of vitamin A acetate, vitamin A palmitate, vitamin D3 and vitamin E succinate were 1.51,
0.52, 1.38, and 3.28 µg/mL, respectively, while their LOQ values were 2.71, 1.56, 4.19 and
9.94 µg/mL, respectively. Obviously, the vitamin E succinate had the lowest instrumental
LOD (3.28 µg/mL) and LOQ (9.94 µg/mL) values.
Moreover, analytical stability in terms of the intra-day (n=6) and inter-day (n=5)
variabilities of the measured three concentrations (i.e., 25, 100, 250 µg/mL) of all the four
FSVs were calculated in order to evaluate the precision of the method. The intra-day and
inter-day variabilities of the four FSVs were expressed as relative standard deviations
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(RSDs), which are listed in Table 2.10. The intra-day variabilities for all four FSVs ranged
from 0.76% to 2.32%, whereas the associated inter-day variabilities were relatively larger,
which ranged from 2.12%-6.31%. Therefore, the precision of the analytical method for all
the samples in three concentration levels was regarded as good, and well controlled within
the acceptable range, which is under 15% according to the FDA regulation (US Food and
Drug Administration, 2001).
Finally, in order to evaluate the accuracy of the developed method, experiments of
the extraction recovery were performed by spiking the MVM samples with the mixture of
the four FSVs standards at three different concentrations (25, 50, and 100 µg/mL). All the
sample preparation steps were performed as same as the developed method mentioned in
Section 2.2.4, with the 0.4 N HCl solution mixed with the MVM samples at 50°C for 2
min. As shown in Table 2.11, the recoveries of the two vitamin A esters are in a range
within 92%-106% at three different concentrations. In comparison, the recoveries of the
vitamin D3 and vitamin E succinate are ranged at relatively lower levels, from 87%-90%
and 78%-84%, respectively.
2.4. Conclusion
Based on the aforementioned results, adding hot HCl solution rather than hot water,
along with vigorous mixing, could provide higher efficiency to extract the four FSVs from
the MVM samples. Other factors that could influence the extraction efficiency included the
extraction temperature, extraction time, concentration of the hydrolysis solution, as well as
the extraction solvent. Based on the RSM experiments, it was confirmed that the FSVs
could be extracted with the best yields under the following hydrolysis condition: 0.4 N HCl
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solution (50.0°C) mixed with the MVM sample for 2.0 min. Then the hydrolysate was
mixed with methanol, followed by extraction by the solvent mixture of hexane:ethyl acetate
(70:30, v/v).
Based on the method mentioned above, it was found that the LODs and LOQs for
the fours FSVs were at acceptable levels, within the range from 1.51 to 3.28 µg/mL for the
LODs, and 2.71 to 9.94 µg/mL for the LOQs.
The recoveries of the two vitamin A esters were found in a range from 92% to 106%
at three different concentrations, though the recoveries of vitamin D3 and vitamin E
succinate had relatively lower values ranging from 87% to 90% and 78% to 84%,
respectively.
Furthermore, it is worthy of mention that few HPLC methods have reported the
determination of vitamin E succinate with other FSVs simultaneously. In the current
research, a successful separation of the four FSVs has been achieved with a good
chromatographic resolution in a single run, regardless of the complex components in the
MVM supplements that could exert significant interference on the analytes. Nevertheless,
further improvement of the extraction recovery and analytical sensitivity will be explored
in the future, particularly, in regards of continuous progress of the encapsulation
technology innovation for the protection of the sensitive FSVs, which, on the other hands,
has provided new challenges for efficient extraction of the vitamins.
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In summary, this study has developed a new method that allowed an easy, rapid
and effective extraction, as well as a simultaneous determination of the four FSVs from
MVM supplements.
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Table 2.1
Literature review
Sample Type

Vitamins Contained

Column

Pharmaceutical
tablet

retinol, retinol acetate,
D2, D3, α-tocopherol,
tocopherol acetate

MetaChem Polaris
C18-A

Sample preparation:

Standard Reference
Material: SRM 3280
Sample preparation:
Animal feeds

Sample preparation:

Animal product

Mobile Phase
0.010%
TFA:methanol
gradient (0.7
mL/min)

Detector

Reference

DAD

(Klejdus et
al., 2004)

Tablets were homogenized and then dissolved in solution 0.010% TFA : methanol (50:50). Stir on
vortex for 15min. Homogenates were evaporated and reconstitute in 0.010% TFA: methanol
(50:50) and filtered for injection.
methanol:acetonitrile
with 5 mmol/L
retinyl acetate, α(Phinney et
MS
ammonium acetate
tocopherol, D2, D3, K1
al., 2011)
(40:60) isocratic
(1.0 mL/min)
Tablets were grounded and mixed with 1% acetic acid. Vortex for 30s and sonicated (no heat) for
30min. After centrifuge, supernatant was transferred and filtered for injection.
ACE C18 from
Advanced
Chromatography
Technologies

Retinyl acetate, D3, αtocopherol, tocopherol
acetate

Waters Atlantis
dC18

methanol:water
(98:2) isocratic
(1.0 mL/min)

UV-vis

(Xue, You, &
He, 2008)

Savinase proteinases was added to feed sample. After 2% ammonia solution was added, the mixture
was shaken in ultrasonic bath at 40-50°C for 20-30min. Ethanol was then added to extract the free
vitamins. After centrifuge, the supernatant was cleaned by SPE for injection.
Tocopherols, retinol,
D3

Waters µPorasil
column
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hexane:diisopropyl
ether gradient
(1.5 mL/min)

UV,
fluorescence

(SaloVäänänen et
al., 2000)

Table 2.1 (Continued)
Literature Review
Sample Type
Sample preparation:

biological fluids
Sample preparation:
Bovine milk

Sample preparation:

Infant formula

Sample preparation:

Vitamins Contained

Column

Mobile Phase

Detector

Reference

Milk sample: saponification, after that water and hexane-ethyl acetate were added to extract FSVs.
After shaken, organic layer was evaporated with nitrogen and redissolved in hexane for injection.
Retinol, D3, αtocopherol, ẟtocopherol,
tocopherol acetate

Phenomenex Luna
C18

methanol:acetonitrile
gradient
(1.3 mL/min)

DAD

(Chatzimichalakis,
Samanidou, &
Papadoyannis,
2004)

UV-vis

(Plozza, Trenerry,
& Caridi, 2012)

Biological fluids were treated using SPE cartridges
trans-retinol, αtocopherol, beta
carotene

Polaris C18-A

water:methanol
linear gradient
(0.2 mL/min)

Sample was mixed with ascorbic acid, ethanol and KOH solution and heated with stirring for
30min. Hexane mixed with ethanol solution was used to extract the FSVs. The hexane layer was
dried with nitrogen and reconstituted with methanol for injection.
Retinol acetate, δ-,
(Mendoza, Pons,
methanol
γ-, α-tocopherol and Tracer Spherisob
Bargalló, &
isocratic
PDA
α-tocopherol
Lopez-Sabater,
ODS2 C18
(1.0 mL/min)
acetate
2003)
Dichloromethane and methanol were added to the fat milk sample. After shaken for 30min, water
was added and shaken before layer separation. The dichloromethane layer was collected. After
evaporation, residue was redissolved in diethyl ether and evaporated again. Lipid residuum was
redissolved in ethanol, following with hexane added. After centrifuge, top layer was collected for
filtration and injection.
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250

250

SPD-M20A-285 nm

Column: Agilent Poroshell 120 EC-C18
(4.6 x 100 mm, 2.7µm)
Mobile phase: (A) 0.2% Formic acid
buffer and (B) methanol
Flow rate: 1.0 mL/min
Gradient elution

2

150

200

150
4

100

100

1

50

0
0.0

mAu

mAu

mAu

200

50

3

2.5

5.0

7.5

10.0

12.5

15.0

17.5

20.0

22.5

0
25.0

Minutes

Figure 2.1 Chromatogram of mixed standards of four FSVs: 1. Retinyl acetate, 2. Cholecalciferol, 3. d-a-tocopheryl
acid succinate, 4. Retinyl palmitate, using HPLC-DAD under 285 nm wavelength.
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Table 2.2
Comparison of treatments to remove the encapsulation coatings of FSVs
Treatment

Vit A Ace

Vit A Pal

Vit D3

Vit E Suc

Observed
(µg/mL)

Percentage
to control

Observed
(µg/mL)

Percentage
to control

Observed
(µg/mL)

Percentage
to control

Observed
(µg/mL)

Percentage
to control

1.0 N HCl2 min
(Control)

78.14±2.16 a

100.0%

93.46±3.04 a

100.0%

86.48±2.21 a

100.0%

75.71±2.32 a

100.0%

0.1 N HCl2 min

55.18±4.62 b

70.6%

60.61±2.19 b

64.9%

80.77±1.58 a

93.4%

80.74±1.27 a

106.6%

D.I. Water2 min

7.83±1.13 cd

10.0%

8.03±0.03 cd

8.6%

22.37±2.62 b

25.9%

68.69±4.03 a

90.7%

D.I. Water4 min

11.08±1.68 c

14.2%

13.49±2.90 c

14.4%

26.41±2.94 b

30.5%

69.19±7.19 a

91.4%

D.I. Water6 min

4.39±0.73 d

5.6%

6.55±0.92 d

7.0%

6.52±0.50 c

7.5%

41.83±2.56 b

55.3%

D.I. Water8 min

2.88±0.60 d

3.7%

4.77±2.28 d

5.1%

4.54±5.91 c

5.3%

36.81±13.91 b

48.6%

Results were expressed as mean ± standard deviation (n=3). Different letters followed the values in the same column indicate
significant difference (p<0.05)
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a
b

c

c
a

a

c
a

a
b

b
b

d
0.4

concentration

0.7

c

Vit E Suc

a
0.1

b

Mean

Vitamin
Vit A Pal
Vit D3

90
80
70
60
50
90
80
70
60
50
90
80
70
60
50
90
80
70
60
50

Mean
Vit A Ace

Observed (µg/mL)

Effect of HCl Concentration

1.0

Figure 2.2 Effect of the HCl solution concentration (0.1, 0.4, 0.7, and 1.0 N) on the
extraction efficiency of four FSVs from MVM supplement, which were mixed with the
respective HCl solutions at 80°C for 2 min. Results expressed as mean with standard
deviation (n=3). Different letters below the error bars in the same row indicate significant
difference (p<0.05).
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Eﬀect of HCl Reaction Time
a

80

b

70

b

b

60

b

Vit A Ace

90

Mean

50
90

b

60

bc

cd

50
90

ab

70

a

d

b

c

c

bc

c

c

Vit D3

80

Vitamin

Observed (μg/mL)

70

Vit A Pal

a

80

60
50

a

80

ab

70
60

VIt E Suc

90

50
0

1

2

3

4

5

6

7

8

9

Time

Figure 2.3 Effect of the hydrolysis time on the extraction efficiency of four FSVs from
the ground MVM supplement samples, which were mixed with 0.4 N HCl solution at
80°C. Results expressed as mean with standard deviation (n=3). Different letters below
the error bars in the same row indicate significant difference (p<0.05).
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Eﬀect of HCl Temperature
a

80
70
60

b

bc
c

110
100
90

VIt A Pal

a

80
70
60

80
70
60

a

a

80
70
60
40

45

50

b

a

a

a
55

60

b

b
Vit E Suc

110
100
90

b

Vit D3

110
100
90

a

65
70
75
HCl Temperature

80

Vitamin

Observed (μg/mL)

Vit A Ace

110
100
90

Mean

a
85

90

95

100

Figure 2.4 Effect of the temperature (50, 65, 80, and 95°C) on the extraction efficiency
of four FSVs from MVM supplement samples, which were mixed with the 0.4 N HCl
solution for 2 min. Results expressed as mean with standard deviation (n=3). Different
letters below the error bars in the same row indicate significant difference (p<0.05).
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Tablet 2.3
Effects of different extraction solvents on the extraction efficiency of four FSVs from MVM supplement samples
Vit A Ace

Vit A Pal

Vit D3

Vit E Suc

Hexane

46.34±3.37 d

51.87±4.55 d

43.75±3.38 d

42.65±4.74 d

Hexane: Methylene dichloride = 50:50

60.85±5.91cd

68.25±2.62 bc

59.39±3.21c

60.51±4.03 c

Hexane: Ethyl acetate = 70:30

96.70±6.78 a

95.90±1.06 a

87.21±3.17 a

84.70±7.00 a

Hexane: Ethyl acetate = 90:10

78.65+4.83 b

79.79±8.59 ab

74.13±2.76 b

82.19±3.67 a

Petroleum ether: Ethyl acetate = 50:50

50.87±1.77 d

46.06±3.93 d

40.42±2.09 d

46.10±2.07 cd

Petroleum ether: Ethyl acetate = 90:10

49.25±2.65 d

54.25±5.68 d

50.26±4.01d

60.77±7.16 bc

Petroleum ether: Chloroform: Ethanol =
60:35:5

65.01±7.55 bc

72.07±6.07 b

70.51±6.22 bc

75.68±7.60 ab

Hexane: Chloroform = 50:50

55.92±3.72 cd

55.24±5.52 cd

54.79±4.97 cd

56.71±5.24 cd

Extraction Solvent

(µg/mL)

(µg/mL)

(µg/mL)

(µg/mL)

Results were expressed as mean ± standard deviation (n=3). Different letters followed the values in the same column indicate
significant difference (p<0.05).
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Table 2.4
Box–Behnken design of RSM for FSVs and the actual values vs. predicted values

Run

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

X1:
HCl
time
(min)
2 (0)
3 (1)
2 (0)
2 (0)
2 (0)
2 (0)
1 (-1)
1 (-1)
2 (0)
1 (-1)
2 (0)
2 (0)
1 (-1)
3 (1)
2 (0)
3 (1)
3 (1)

X2:
HCl
conc.
(N)
0.4 (0)
0.4 (0)
0.7 (1)
0.4 (0)
0.4 (0)
0.7 (1)
0.4 (0)
0.7 (1)
0.4 (0)
0.4 (0)
0.1 (-1)
0.4 (0)
0.1 (-1)
0.7 (1)
0.1 (-1)
0.4 (0)
0.1 (-1)

X3:
HCl
temp.
(°C)
50 (0)
35 (-1)
35 (-1)
50 (0)
50 (0)
65 (1)
35 (-1)
50 (0)
50 (0)
65 (1)
35 (-1)
50 (0)
50 (0)
50 (0)
65 (1)
65 (1)
50 (0)

FSVs extraction yields (*106)
Vitamin A
palmitate
Vitamin D3

Vitamin A
acetate
Actual
value
6.25
4.69
4.59
6.27
6.27
6.11
5.39
5.56
6.18
6.20
4.92
6.18
5.39
4.82
5.89
6.33
5.61

Predicted
Value
6.23
4.69
4.53
6.23
6.23
6.04
5.38
5.63
6.23
6.19
4.99
6.23
5.33
4.88
5.95
6.34
5.54

Actual
value
15.79
14.71
13.54
15.56
15.66
14.68
10.59
13.05
15.92
13.53
12.75
16.85
12.14
16.58
14.51
15.27
14.43

Predicted
Value
15.96
14.78
13.57
15.96
15.96
15.17
10.67
13.09
15.96
13.46
12.57
15.96
12.09
16.01
14.17
15.19
15.01

Actual
value
6.26
4.24
3.98
6.23
6.13
5.15
2.97
4.02
6.03
3.59
4.03
6.28
3.90
5.27
3.41
3.83
4.08

Predicted
Value
6.19
4.19
3.97
6.19
6.19
5.06
2.94
4.06
6.19
3.64
4.12
6.19
3.84
5.33
3.41
3.86
4.04

Vitamin E
succinate
Actual
value
0.81
0.44
0.51
0.81
0.85
0.79
0.40
0.48
0.84
0.42
0.51
0.83
0.32
0.57
0.43
0.51
0.49

Predicted
Value
0.83
0.45
0.51
0.83
0.83
0.76
0.36
0.49
0.83
0.43
0.54
0.83
0.34
0.59
0.43
0.53
0.44

Numbers in the parentheses are coded level (-1, 0, 1) for each extraction variable. Yields are represented by peak area of each
FSV at corresponding wavelength during HPLC analysis.
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Table 2.5
ANOVA table for response surface quadratic model of vitamin A acetate
Source

D.f.

Model
9
X1
1
X2
1
X3
1
X1*X2
1
X1*X3
1
X2*X3
1
X1*X1
1
X2*X2
1
X3*X3
1
Residual
7
C. Total
16
Lack of fit 3
Pure error 4
R2
Adj R2
* significant (p<0.05)

Sum of squares
Mean square F value
(SS)

P-value
(Prob>F)

6.08E+12
1.49E+11
6.65E+10
3.05E+12
2.31E+11
1.77E+11
7.59E+10
3.94E+11
1.41E+12
3.18E+11
4.08E+10
6.12E+12
3.30E+10
7.75E+09
0.9933
0.9848

6.76E+11
1.49E+11
6.65E+10
3.05E+12
2.31E+11
1.77E+11
7.59E+10
3.94E+11
1.41E+12
3.18E+11
5.82E+09

116.00
25.65
11.41
523.65
39.59
30.38
13.03
67.67
242.01
54.57

<.0001*
0.0015*
0.0118*
<.0001*
0.0004*
0.0009*
0.0086*
<.0001*
<.0001*
0.0002*

1.10E+10
1.94E+09

5.683

0.0633
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Table 2.6
ANOVA table for response surface quadratic model of vitamin A palmitate

Source
Model
X1
X2
X3
X1*X2
X1*X3
X2*X3
X1*X1
X2*X2
X3*X3

D.f.
9
1
1
1
1
1
1
1
1
1
7
16
3
4

Residual
C. Total
Lack of fit
Pure error
R2
Adj R2
* significant (p<0.05)

Sum of squares
(SS)
4.28E+13
1.71E+13
2.02E+12
5.11E+12
3.87E+11
1.42E+12
9.29E+10
5.32E+12
2.57E+12
7.17E+12
1.66E+12
4.45E+13
5.94E+11
1.07E+12
0.9626
0.9146

Mean square
4.76E+12
1.71E+13
2.02E+12
5.11E+12
3.87E+11

F value
20.03
71.80
8.50
21.54
1.63

P-value
(Prob>F)
0.0003*
<.0001*
0.0225*
0.0024*
0.2424

1.42E+12
9.29E+10
5.32E+12
2.57E+12
7.17E+12
2.37E+11

5.96
0.39
22.38
10.84
30.20

0.0447*
0.5515
0.0021*
0.0133*
0.0009*

1.98E+11
2.67E+11

0.7404

0.5809
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Table 2.7
ANOVA table for response surface quadratic model of vitamin D3

Source
Model
X1
X2
X3
X1*X2
X1*X3
X2*X3
X1*X1
X2*X2
X3*X3

D.f.
9
1
1
1
1
1
1
1
1
1
7
16
3
4

Residual
C. Total
Lack of fit
Pure error
R2
Adj R2
* significant (p<0.05)

Sum of squares
(SS)
2.09E+13
1.08E+12
1.12E+12
7.08E+10
2.87E+11
2.67E+11
8.07E+11
5.85E+12
2.03E+12
7.70E+12
7.89E+10
2.09E+13
3.57E+10
4.32E+10
0.9962
0.9914

Mean square
2.32E+12
1.08E+12
1.12E+12
7.08E+10
2.87E+11

F value
205.69
95.66
99.34
6.28
25.51

P-value
(Prob>F)
<.0001*
<.0001*
<.0001*
0.0406*
0.0015*

2.67E+11
8.07E+11
5.85E+12
2.03E+12
7.70E+12
1.13E+10

23.73
71.56
518.61
179.76
682.84

0.0018*
<.0001*
<.0001*
<.0001*
<.0001*

1.19E+10
1.08E+10

1.1019

0.4456
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Table 2.8
ANOVA table for response surface quadratic model of vitamin E succinate

Source
Model
X1
X2
X3
X1*X2
X1*X3
X2*X3
X1*X1
X2*X2
X3*X3

D.f.
9
1
1
1
1
1
1
1
1
1
7
16
3
4

Residual
C. Total
Lack of fit
Pure error
R2
Adj R2
* significant (p<0.05)

Sum of squares
(SS)
5.45E+11
1.79E+10
4.51E+10
1.13E+10
1.73E+09
7.54E+08
3.29E+10
2.43E+11
6.28E+10
8.82E+10
7.25E+09
5.52E+11
5.68E+09
1.57E+09
0.9869
0.9700

Mean square
6.06E+10
1.79E+10
4.51E+10
1.13E+10
1.73E+09

F value
58.49
17.29
43.56
10.95
1.68

P-value
(Prob>F)
<.0001*
0.0043*
0.0003*
0.0129*
0.2366

7.54E+08
3.29E+10
2.43E+11
6.28E+10
8.82E+10
1.04E+09

0.73
31.78
235.15
60.66
85.17

0.4218
0.0008*
<.0001*
0.0001*
<.0001*

1.89E+09
3.92E+08

4.8315

0.0811
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Figure 2.5 Response surface plots of vitamin A acetate extraction yield affected by hydrolysis time (X1), HCl
concentration (X2), and hydrolysis temperature (X3)
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Figure 2.6 Response surface plots of vitamin A palmitate extraction yield affected by hydrolysis time (X1), HCl
concentration (X2), and hydrolysis temperature (X3)
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Figure 2.7 Response surface plots of vitamin D3 extraction yield affected by hydrolysis time (X1), HCl concentration
(X2), and hydrolysis temperature (X3)
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Figure 2.8 Response surface plots of vitamin E succinate extraction yield affected by hydrolysis time (X1), HCl
concentration (X2), and hydrolysis temperature (X3)
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Table 2.9
Calibration data, LOD, LOQ of the four FSVs
Parameters

Vit A Ace

Vit A Pal

Vit D3

Vit E Suc

325

325

265

285

1.25-400

1.25-400

6.25-400

12.5-400

y = 15046x + 56537

y = 100274x - 1044

y = 47053x + 60848

y = 3269x + 6483.9

0.9993

0.9998

0.9999

0.9986

LOD (µg/mL)

1.51

0.52

1.38

3.28

LOQ (µg/mL)

2.71

1.56

4.19

9.94

Wavelength (nm)
Linear range (µg/mL)
Linear equation
Coefficient of
Determination (R2)
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Table 2.10
Intra-day and inter-day precision determined at three concentration levels

Component

Concentration
(µg/mL)

RSD (%)

Vitamin A Ace

25
100
250

Intra-day
1.48
0.76
1.02

Vitamin A Pal

25
100
250

2.12
0.95
1.07

5.16
4.23
2.69

Vitamin D3

25
100
250

2.32
1.46
2.28

6.03
5.93
4.22

Vitamin E Suc

25
100
250

1.99
2.31
1.76

6.31
4.77
4.35
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Inter-day
4.14
3.67
2.12

Table 2.11
Extraction recovery (%) of the four FSVs spiked at three different levels into the MVM
supplements samples
Spiked
(µg/mL)

Recovery
(%)

Vit A Ace

25
50
100

94
97
106

Vit A Pal

25
50
100

92
95
99

Vit D3

25
50
100

89
90
87

Vit E Suc

25
50
100

78
80
84

Compound
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CHAPTER THREE
STABILITY STUDY OF ENCAPSULATED FAT-SOLUBLE VITAMINS
Abstract
Previous studies have reported that several factors including temperature, light, pH,
moisture content, and oxygen could induce degradation of fat-soluble vitamins in different
food matrices. This study discussed the degradation trend of encapsulated FSVs (i.e.
vitamin A acetate, vitamin A palmitate, vitamin D3 and vitamin E succinate) when they
were dispersed in aqueous system and stored in dry form under different treatments,
including light exposure, temperature (25°C, 30°C, 40°C, 60°C), acid or alkaline condition
(pH=3, 5, 7, 9), and different temperature/humidity environments for five consecutive
days. Exposure to light resulted in degradation of the FSVs, especially in larger extent for
two vitamin A esters (i.e. acetate form and palmitate form). Different FSVs exhibited
various degrees of degradation when dispersed in the acid or alkaline solutions. The
degradation of the FSVs dispersed in aqueous system under thermal treatments, as well as
the encapsulated dry form of FSVs treated under the temperature/humidity conditions
during 93 days of storage, were found to fit the first-order kinetic models. The reaction rate
constants for degradation of the four FSVs, including the vitamin A acetate, vitamin A
palmitate, vitamin D3 and vitamin E succinate, in aqueous system were calculated to be in
a range of 0.038-0.398 day-1, 0.063-0.939 day-1, 0.091-1.234 day-1, and 0.116 -1.515 day-1
at 25°C, 30°C, 40°C, and 60°C, respectively. The retention percentage of the encapsulated
dry form of FSV powders were around 61.1% - 71.2% at the 25°C/60% RH condition after
93 days of storage. As the temperature/humidity increased, faster degradation occurred.
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3.1. Introduction
Fat-soluble vitamins (FSVs) are a group of essential nutrients that ensure normal
body function, optimal growth, and reproduction (Goncalves et al., 2015). It is known that
stability of FSVs can be affected by several factors including temperature, pH, light,
moisture content, presence of oxygen, metal trace elements, etc. (Ball, 2005). Several
studies have demonstrated the effect of those aforementioned factors on the degradation of
the FSVs in different matrices. Therefore, the FSVs are always recommended to be handled
carefully in sealed dark containers under an inert atmosphere.
Vitamin A is hardly soluble in water and very sensitive to oxidants, temperature,
light, trace minerals, and moisture (Gonnet, Lethuaut, & Boury, 2010). Exposure to
chemicals such as acids, oligoelement, and peroxides can lead to the degradation of vitamin
A, especially when the temperature and humidity conditions are higher than normal
(Albertini, Di Sabatino, Calogerà, Passerini, & Rodriguez, 2010). On the other hand, retinol
and retinyl esters can react with one another, forming dimers of vitamin A derivatives
called kitols and kitol esters (Runge & Heger, 2000). The dimers are either produced in a
thermally induced Diels-Alder reaction or photochemically induced reaction (Burger &
Garbers, 1973). The vitamin A degradation or kitol formation can be remarkably
accelerated if the sample is illuminated under an oxygen-free condition. On the other hand,
a thermally induced degradation could also occur under darkness and inert conditions
(Runge & Heger, 2000).
Besides, a previous study reported that free a-tocopherol could be degraded to 60%
of its original concentration when it was treated in darkness at 40°C in 6 hours. Under the
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same condition mentioned above, its degradation could be delayed when it was dissolved
in organic solvents such as methanol and hexane (Sabliov et al., 2009). However, when atocopherol was dissolved in methanol in the presence of light, a drastic degradation was
observed because methanol was able to absorb UV light to form methoxy radicals and
hydroxyperoxyl radicals, as well as hydrogen peroxide that enhanced the oxidation of
vitamin E. At the same time, a-tocopherol oxy radicals was also induced to cause its selfdegradation (Hales & Case, 1981; Schinke, 1995). Degradation of a-tocopherol followed
a mathematical model in first order kinetics when it is in hexane or free form, or in second
order kinetics when it is dissolved in methanol (Sabliov et al., 2009). There are two main
forms of vitamin E used in dietary supplements, which are a-tocopheryl acetate and atocopheryl succinate that carry either an acetyl group or a succinyl group to increase the
stability of vitamin E in the presence of oxygen and light (Schneider, 2005).
Previous studies have revealed photochemically, chemically and thermally induced
isomerization, as well as oxidation chemistry of vitamin D3, which is sensitive to light,
high temperature and oxygen (Ballard, Zhu, Nelson, & Seburg, 2007). As shown in Figure
3.1, vitamin D3 can be thermally isomerized to pre-vitamin D3 which is an intermediate
during the formation of vitamin D3 from 7-dehydrocholesterol (Ballard et al., 2007). In
addition, acid can also induce the degradation of vitamin D3 to form isotachysterol (Jin,
Yang, Yang, Liu, & Zhang, 2004). At the meantime, tachysterol, which is a 7,8 cis-isomer
of isotachysterol as well as pre-vitamin D3 could also be formed under UV light exposure
(Figure 3.1) (Mahmoodani, Perera, Fedrizzi, Abernethy, & Chen, 2017). However,
conflicting results exist with respect to the stability of vitamin D3. A previous study
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reported that vitamin D3 was unstable to light, oxidation and acid, whereas some others
argued it was stable to acid and alkali (Cremin & Power, 1985; Kutsky, 1981). Some
studies claimed that the vitamin D3 fortified in processed dairy products was relatively
stable (Kazmi, Vieth, & Rousseau, 2007; Wagner et al., 2008), whereas some researchers
reported a significant degradation of the vitamin D3 after it was added to a traditional
system, such as water-ethanol mixture (Abbasi, Emam-Djomeh, Mousavi, & Davoodi,
2014). Those contradictory statements revealed that the stability of vitamin D3 might
depend on what food matrices it is in, as well as the presence of oxygen and light exposure.
In order to prevent the FSVs from pro-oxidant elements that can affect their
chemical integrity, encapsulation is often employed as an effective means. By providing a
physicochemical barrier against the adverse environmental factors such as undesirable UV
light, oxygen, free radicals, etc., encapsulation has provided an effective method to control
the release, extend the shelf life, and enhance the biological efficiencies of active
ingredients, such as FSVs (Gonnet et al., 2010). In addition, the encapsulation is an ideal
solution to make the FSVs soluble in aqueous system (Abbasi et al., 2014). In regard to the
wall materials of encapsulation, chemicals such as carbohydrates, lipids, cellulose and its
derivatives, gums, and some proteins are commonly adopted (Bertolini, Siani, & Grosso,
2001). One study investigated the stability of vitamin D3 entrapped in the whey protein
isolate (WPI) nanoparticles, and reported that WPI nanoparticles could significantly delay
the vitamin D3 degradation in presence of oxygen (Abbasi et al., 2014).
After a comprehensive review of the previous research, I found that relatively few
studies had evaluated the stability of the encapsulated FSVs subject to the adverse
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environmental factors. Therefore, the current work aimed to study the stability of the
encapsulated vitamin A (retinyl acetate, retinyl palmitate), vitamin D3 (cholecalciferol) and
vitamin E (d-a-tocopheryl acid succinate), which were commonly used in the nutraceutical
or pharmaceutical products. Influence of the factors such as temperature, relative humidity,
pH, light, and degradation kinetics of the four FSVs have been evaluated and will be
described below.

3.2. Material and Methods
3.2.1. Chemicals and reagents
Raw materials, including retinyl acetate, retinyl palmitate, vitamin D3 and d-atocopheryl acid succinate, which were used for dietary supplement manufacturing were
generously provided by Nutra Manufacturing Inc (Anderson, SC, USA). Water dispersible
forms of retinyl acetate powder and vitamin D3 powder were kindly provided by PAT
Vitamins Inc (La Verne, CA, USA). Water-dispersible form of retinyl palmitate was
purchased from MP Biomedicals (Solon, OH, USA). All of the chemical standards,
including retinyl acetate, retinyl palmitate, cholecalciferol, and d-a-tocopheryl acid
succinate, were purchased from Sigma-Aldrich (Milwaukee, USA). Hydrochloric acid
(37%) and formic acid (99%) for analysis were obtained from Acros Organics (New Jersey,
USA). Alcohol 200 Proof was purchased from Decon Laboratories Inc (Pennsylvania,
USA). HPLC-grade hexane and ethyl acetate were purchased from Fisher Scientific
(Atlanta, GA, USA). Deionized water was obtained through a Milli-Q water purification
system (Millipore, Bedford, MA, USA).
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3.2.2. Experiment Design
3.2.2.1. FSV extraction and HPLC-DAD method
In order to extract the FSVs for the subsequent quantitative analysis, 0.25 mL of
each FSV sample solution that needs to be tested was collected and transferred into a
centrifuge tube covered with aluminum foil. One mL of 0.4 N HCl solution was heated to
80°C and added into the FSV solution. Then, the sample was vigorously mixed on a vortex
mixer for 2 minutes, followed by adding 5 mL of a solvent mixture of hexane:ethyl acetate
(70:30, v/v) for the FSVs extraction. The mixture was then mixed by a rotary mixer for 30
minutes followed by a centrifugation at 3000 rpm in darkness at 4°C for 10 min. Finally,
the supernatant was transferred into an amber vial, and dried by purging with nitrogen gas
and reconstituted with ethanol. The sample was then filtered through 0.22 µm nylon
membrane prior to the HPLC analysis. The analytical method of HPLC was the same as
that described in Section 2.3.1 of Chapter Two. All experiments were conducted in
triplicates.
3.2.2.2. Sample preparation
In order to simulate the application of the FSVs in aqueous system of dietary
supplements such as functional drinks, or other kinds of beverages, water dispersible forms
of four FSVs powder, including vitamin A acetate, vitamin A palmitate, vitamin D3, and
vitamin E succinate, were used to investigate their degradation models. The FSVs powders
were accurately weighed at 0.5g on a Fisher Scientific XA-200DS analytical balance, and
respectively transferred into individual 250 mL volumetric flasks covered with aluminum
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foil. Then, 250 mL of D.I. water was added. After that, each of the volumetric flasks was
placed on a magnetic stirring plate until the powders were evenly dispersed in the D.I.
water. Finally, each of the FSV dispersed solutions was pipetted out by 10 mL each time
for 5 times, which were respectively transferred into five 50 mL centrifuge tubes for
storage, and treated by the following parameters in terms of light and temperature that will
be described in detail in the following sections. At each designated test point, samples will
be taken from those stored tubes for HPLC analysis to evaluate the effects of the light and
temperature on the stability of the FSVs. Each sample was prepared and treated in
triplicate.
3.2.2.3. Effect of the light
The control group of the four FSVs samples were placed in centrifuge tubes covered
with aluminum foil in the dark condition at room temperature (RT), whereas the other
group of the four FSVs were completely exposed to fluorescent light (2200 lumens) at the
same temperature (25°C). The photochemical degradation of those fat-soluble
multivitamin components was measured every day in 5 consecutive days under the light
and dark conditions. During the period, samples of each FSVs were taken at the same time
every day, transferred into new centrifuge tubes for extraction, and subject to the HPLC
analysis based on the method described in Chapter Two.
3.2.2.4. Effect of temperature
The four FSVs mixtures were placed in individual tubes at four temperatures: room
temperature (25°C), 30°C, 40°C, and 60°C. The control group was placed in the room
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temperature (25°C) in darkness. The other three groups were kept in separate water baths
at the aforementioned temperatures in dark condition. The thermal degradation of each
FSV was evaluated by measuring the remaining concentration of each FSV that was
incubated at 4 different temperatures each day for a total of 5 consecutive days. Other steps
in terms of extraction and HPLC analysis were as same as those previously described
above.
3.2.2.5. Effect of pH
Four water solutions were prepared in different pH (pH=3, 5, 7, and 9) values,
which were adjusted by dilution of hydrochloric acid (HCl) and sodium hydroxide (NaOH)
with a pH meter. Each of the four FSV powders was accurately weighed on an analytical
balance and transferred into individual centrifuge tubes covered with aluminum foil, which
were added respectively with the four solutions (pH=3, 5, 7, 9). The mixtures were then
placed on a rotary mixer until the powders were evenly dispersed in the water solution.
Finally, the mixtures were stored in the darkness condition at room temperature. Other
procedures in terms of extraction and HPLC analysis were as same as those previously
described above.
3.2.2.6. Stability of encapsulated FSVs in dry form
In order to evaluate the stability of the encapsulated FSVs powders in a solid form
as their common existence in dietary supplements, the FSV powders were kept in their dry
forms in different conditions. Each of the FSV powders was sealed in separate whirl-pak
bags (Nasco) and placed in a light-proof plastic container in five different conditions:
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25°C/60% RH (relative humidity), 30°C/65% RH, 30°C/75% RH, 40°C dry, 40°C/75%
RH. Those five conditions were selected based on the International Council for
Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
Guidelines, which defines the specific conditions for long term or accelerated stability test
of pharmaceutical formulations (ICH Guideline, 2003). In this study, the concentrations of
FSVs in the powders were analyzed at different time intervals (i.e., 0, 1, 2, 5, 9, 16, 23, 37,
51, 65, 79, and 93 day) within 93 days. During the period, the samples were weighed
accurately on an analytical balance, and then extracted by the aforementioned method,
followed by the HPLC-DAD analysis.
3.2.2.7. Degradation kinetics analysis
The percentage of each remaining vitamins was calculated by the following
equation
%Retention =

)!
× 100
)"

(1)

where )! is the concentration of the vitamin at time t, and )" is its initial concentration.
After the review of previous literature, it was found that vitamin loss was suggested
to follow a first order kinetics (Vikram, Ramesh, & Prapulla, 2005).
−

/)
= 1)
/0
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(2)

where ) is the concentration (µg/mL) of the vitamin at time 0 (days), and 1 is the reaction
constant (day-1). If )" is the concentration of each vitamin at the initial time zero,
integration of the above equation yields:
) = )" 2 #$!

(3)

Taking natural logarithm, we obtained
ln ) = ln )" − 10

(4)

)
ln 4 5 = −10
)"

(5)

which is equivalent to

%

For the first order reaction, plotting the ln 6% 7 against the time 0 will generate a straight
!

line, and the slope of this line represents the rate constant of the chemical degradation
(Vikram et al., 2005).
3.2.3. Statistics
All experiment tests were conducted in triplicate. The results were presented as
mean ± standard deviation (SD). The effect of light, temperature, and time on the FSVs
degradation was tested. At each time interval, difference between the treatments was
determined by the Tukey’s test in order to reveal the effects of light, temperature or pH.
Statistical analyses were conducted using the JMP 13.0 (Cary, NC). Probability values less
than 0.05 were considered evidences of statistical significance.
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3.3. Results and Discussion
3.3.1. Encapsulated FSVs in dispersible water system
3.3.1.1 Effect of light (photodegradation)
Figure 3.2 profiles the effect of light on FSVs extracted from the aqueous samples
in the course of time. As a result, all the four FSVs in our samples were fallen into the
expectation that they were all degraded in varying degrees over the course (i.e. 5 days).
A previous study showed that after 16 hours, vitamin A content in nonfat milk
exhibited a 49% reduction when exposed to 2000 lx fluorescent light, and a 32% reduction
after exposure to 1000 lx (Whited, Hammond, Chapman, & Boor, 2002). In regard of the
two vitamin A esters (i.e. retinyl acetate, and retinyl palmitate) in my samples, the results
(Figure 3.2 a & b) demonstrated that the vitamin A esters were highly unstable in the
presence of light. The amount of vitamin A acetate significantly decreased to 10% of its
initial amount after 1 day (p<0.05), in comparison to its retention at 72% under a dark
condition over the same period. Compared to the vitamin A acetate, vitamin A palmitate
exhibited a relatively moderate degradation when exposed to light. After the first day of
exposure to light, 81% of the vitamin A palmitate was remained, while 16% of vitamin A
palmitate was still observed after 3 days of the treatment. In comparison to the control
group (under a dark condition), both of the vitamin A esters have exhibited significantly
lower remaining contents after being exposed to light during the designated test period
(p<0.05). In regard to the vitamin D3 in the samples, no noticeable reduction of its amount
was observed within the first 2 days when the sample was placed in darkness. However, it
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was decreased by 10% when exposed to light during the same period (Figure 3.2 c). After
5 days, the remaining vitamin D3 were determined to be 72% and 78%, respectively, in the
presence and absence of light. In addition, as shown in Figure 3.2 d, only 50% of the
vitamin E succinate in our sample was remained when it was exposed to light for 5 days,
whereas 84% of the compound was observed in the control sample at the same time.
3.3.1.2 Effect of temperature
A previous study has shown that long time exposure to heat could lead to
degradation of FSVs (Lešková et al., 2006). As shown in Figure 3.3, all of the four FSVs
samples displayed significant degradations when treated under higher temperatures (i.e.
30, 40, 60°C) compared to the control sample at 25°C. As expected, more than half (56%,
65%, 65%) of the vitamin A acetate were significantly degraded after 1 day at 30, 40, and
60°C, respectively, and above 93% of them were degraded within the subsequent 2 days
of exposure at those temperatures (Figure 3.3 a). In comparison, the vitamin A acetate in
the control group (25°), which was determined to have a remaining amount of 39%, was
significantly higher than that of other treatments after 3 days (p<0.05). As a comparison,
vitamin A palmitate exhibited a relatively less reduction (11%, 22%, 38%) after 1 day of
treatment at 30, 40, and 60°C, respectively (Figure 3.3 b). However, during the following
2 days, its degradation at 30, 40 and 60°C approached to 75%, 87%, 91% loss, respectively,
which were much more rapid than that of the control sample that was only degraded by
34% when it was kept at 25°C during the same period. After 2 days, significant differences
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(p<0.05) were observed between each treatment, indicating that higher temperature has led
to more severe degradation of the aforementioned vitamins.
Compared to the tremendous degradation of the two vitamin A esters after the high
temperature treatment, the degradation of vitamin D3 and vitamin E succinate was
relatively moderate. The remaining amounts of vitamin D3 and vitamin E succinate were
respectively above 54% of their initial values at all of the temperatures (i.e., thermal
treatments) after 5 days (Figure 3.3 c and d), indicating that less influence has impacted
the aforementioned two vitamins. In details, vitamin D3 stored at 25°C showed a
significantly lower degradation than that stored at other temperatures (p<0.05) starting
from the day 2. In addition, the vitamin D3 residue at 30°C was significantly higher than
that at 40°C after 2 days (p<0.05), whereas no significant difference was observed between
the treatment at 40°C and 60°C. Similar to the case of vitamin D3, the vitamin E succinate
residue in the control group (25°C) was significantly higher than that in all other treatment
groups (i.e. 30, 40, 60°C). In addition, no significant difference of the concentrations of the
vitamin E succinate was observed between 30°C and 40°C, but they were significantly
higher than the one at 60°C (p<0.05) over the first 3 days. However, after 5 days of the
thermal treatment, the residual concentration of vitamin E succinate treated with 30°C was
71%, which was significantly higher than that treated at 40°C and 60°C (58% and 54%,
respectively).
In order to determine the reaction kinetics of the four FSVs, the residues of the
FSVs were analyzed on a natural log transformed base against time (day). According to
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Figure 3.4, it was found that the degradation of the four FSVs as a function of time
followed the first order kinetics. First order degradation rates for the four encapsulated
FSVs dispersed in water were estimated based on the Equation (5) mentioned in Section
3.2.2.7. The reaction rate constants (1) for the FSVs degradation at different temperatures
were listed in Table 3.1. As the results shown, for all of the four FSVs, the 1 value became
larger as the temperature increased, which further confirmed the influence of temperature
on the destruction of the FSVs. In addition, the 8& values were above 0.90 for all four FSVs
when treated with higher temperatures (i.e. 30, 40, 60°C), indicating that the observed
phenomena of the degradation of FSVs in deed obeyed the first order kinetics.
3.3.1.3 Effect of pH
The stability of the encapsulated FSVs powders was also investigated in aqueous
solutions with different pH values (i.e., pH 3, 5, 7, and 9) stored at room temperature for 5
days. The amounts of all four vitamins gradually decreased during the designated time
span. As shown in Figure 3.5 a, the remaining percentage of vitamin A acetate at pH 3
was significantly lower than that in other three groups (i.e. at pH 5, 7, and 9) after the first
and second day of treatment. However, no significant difference of the vitamin degradation
was observed between the latter three conditions. Moreover, significant lower retention
(29%) of the vitamin A palmitate was observed after it was treated at pH 3 for 3 days
(Figure 3.5 b), indicating that the strong acidic condition has adversely affected the
stability of vitamin A. Considering the degradation pattern over the first 3 days, both of the
vitamin A esters exhibited slower reduction when being treated at pH 7 or 9 than that at
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pH 3, suggesting that neutral and a slightly basic condition had less impact than the acidic
condition. Nevertheless, it was also observed that vitamin A acetate was degraded rapidly
and dropped below 30% at all the conditions (i.e. pH 3, 5, 7, 9) after 3 days, whereas
vitamin A palmitate retained 29%, 37%, 60%, and 49% of its initial amount, respectively,
in the aforementioned conditions. This trend conforms to a previous study stating that
vitamin A palmitate had greater stability than vitamin A acetate in general (Rutkowski &
Diosady, 2007). However, it is worthy of mention that, after 5 days of the treatment, the
remaining amounts of the both vitamin A esters were significantly dropped to below 20%
regardless of the type of the vitamins and the pH values of the solution, and there were no
significant differences between the different pH treatments for each vitamin A ester.
Vitamin D3 was observed to be relatively stable under the neutral condition. When
vitamin D3 was exposed to the acid conditions (i.e., pH 3 and pH 5), the percentage of its
retention in both acidic conditions was observed significantly lower than that at the pH 7
condition in the course of the treatment (Figure 3.5 c), indicating the sensitivity of vitamin
D3 to the acids. Although a previous study reported that the pure vitamin D3 could undergo
a rapid acidic hydrolysis leading to a complete degradation within 1 hour (Temova &
Roškar, 2016), my study found that the residual level of the vitamin D3 under the acidic
conditions (i.e., pH 3 and pH 5) were still relatively high (47%, and 52%) after 5 days of
the treatment. This discrepancy might be due to the protection of the vitamin D3
encapsulation. In regards to the vitamin D3 exposed to an alkaline condition (pH 9), its
retention was better than that in the acidic conditions, but significantly lower than the one
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at pH 7 over the course of the treatment, indicating that vitamin D3 is susceptible to the
alkaline condition too.
Vitamin E succinate was observed with a similar degradation profile like vitamin
D3. According to my tests (Figure 3.5 d), the vitamin E succinate also showed an extensive
degradation when it was exposed to a strong acidic condition (pH 3). After 3 days of the
treatment, the residues of the vitamin E succinate were only remained with 44%, 55%, and
54% of their initial amount at both acidic and alkaline conditions (i.e. pH 3, 5, and 9),
which were significantly lower than the level of the compound placed at pH 7 (69%)
(p<0.05). This result, to a certain degree, was consistent to a previous study suggesting that
the vitamin E acetate could be hydrolyzed to free tocopherols when it was exposed to strong
acids or alkalis (Ottaway, 2010).
Based on the above results, it was found that all the tested FSVs in aqueous
solutions were rapidly degraded, regardless of the temperature, pH values and exposure
degree of light, under the aforementioned treatments after 5 days. In this context, the
stability of the encapsulated FSVs in dry forms were further investigated, which is
described below in detail.
3.3.2. Stability of encapsulated FSVs in dry form
In order to explore the stability of the encapsulated FSVs powders that were applied
in solid dosage form during storage, the four aforementioned FSVs in their dry powder
forms were sealed in separate whirl-pak bags placed in five specific conditions mentioned
earlier (denoted as temperature/relative humidity in 25/60, 30/65, 30/75, 40 dry, and
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40/75). The samples were taken at different time intervals during the 93-day period and
analyzed. As shown in Table 3.2, no significant difference was observed between the
retention of vitamin A acetate after 93 days, which were determined to be 61.1%, 58.5%,
57.0% when the samples were stored at 25/60, 30/65, and 40 dry, whereas there was a
significant decrease of the concentration (i.e. 21.3% retention) at the 30/75 condition. It is
noted that both vitamin A acetate and palmitate degraded completely after 51 days when
they were stored under a high temperature/high humidity model at the 40/75 condition
(Figure 3.6 a & b). Besides, the results showed that the vitamin A palmitate degraded in a
way similar to the vitamin A acetate, while the vitamin D3 performed similarly to the
vitamin E succinate. It seems the vitamin D3 was relatively stable at low temperature and
low humidity. Its residual amount (79.4%) at the 25/60 condition appeared to be fairly
higher than that (75.9%, 72.9%, and 75.3%) under the 30/65, 30/75, and 40 dry conditions,
respectively, but no significant difference was found between the aforementioned three
conditions. Nevertheless, the 40/75 condition resulted in the lowest retention of vitamin
D3. In addition, it is worth to be mentioned that during the designated testing period, only
the vitamin D3 powder stored at 40/75 started to clump together over time. Vitamin E
succinate stored at the 25/60 condition remained 71.2% of its original value after 93 days,
which was significantly higher than that stored at all the other conditions (p<0.05). In
addition, its chemical retention (57.5%) at the 30/75 condition was found to be significantly
lower than that at 40 dry (64.7%) and 30/65 (63.9%).
The natural logarithm of the retention percentage of each FSV under the five
conditions in light of temperature/relative humidity was plotted against the storage time.
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As a result, the degradation of the four FSVs were found to follow a first-order kinetic
model (Figure 3.6). The rate constants of the degradation (or the slope of the regression
line) of the FSVs were determined by the equation (4) mentioned earlier (in section
3.2.2.7). The intercepts of the regression lines were forced to zero point. Their values and
the coefficients of determination (R2), are listed in Table 3.3.
The coefficients of determination (R2) of regression lines for the vitamin
degradation under different conditions were found within a range of 0.91-0.97 for the
vitamin A acetate and palmitate, with exceptions for them to have relatively lower values
(0.83 and 0.81, respectively) at the 40 dry condition. A notable increase in the degradation
rate was observed when the temperature and relative humidity were both raised to high
levels for the vitamin A esters (in acetate and palmitate forms). Especially, at the 40/75
condition, both of the vitamin A acetate and palmitate exhibited much higher degradation
rates at 0.0846 day-1 and 0.0939 day-1, respectively, than them stored at the other four
conditions, which ranged from 0.0055 day-1 to 0.0141 day-1. Besides, a remarkable
difference of the degradation rates was observed at the same temperature but different
relative humidity conditions for storage of the two vitamin A esters. For example, when
the vitamin A acetate was stored at 30°C, its degradation rate was higher when the relative
humidity of storage was higher (0.0141 day-1 for 75% RH vs. 0.0070 day-1 for 65% RH).
When the temperature was raised to 40°C, their difference was more obvious (0.0846 day1

for 75% RH vs. 0.0075 day-1 for 40 dry) (p<0.05). The same scenario was also found for

the vitamin A palmitate. The results demonstrated that humidity played an important role
in the storage of the vitamin A powders because it could accelerate the degradation rate.
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Unlike the vitamin A esters, the degradation of vitamin D3 occurred at relatively
low rates as indicated by smaller degradation constants rates with R2 ranging from 0.82 to
0.96 (Table 3.3). The constant rate of the vitamin D3 degradation at the 40/75 condition
was determined to be the largest (0.0047 day-1) in all five conditions due to the high
temperature level as well as the high humidity environment. Vitamin D3 stored at the 30/75
condition also showed a significantly higher constant rate (0.0036 day-1) than the one stored
at 25/60 condition (0.0023 day-1). Besides, there was no significant difference between the
degradation rates of the vitamin D3 stored at the 30/65 and 40 dry conditions (0.0032 day1

vs. 0.0033 day-1).
Study of the vitamin E succinate also showed that a combined high humidity and

high temperature treatment (i.e. 40/75 condition) had resulted in the highest degradation
rate (0.0066 day-1, R2=0.89) of the vitamin. Although the degradation of vitamin E
succinate stored at the 30/75 condition appeared to be less severe (0.0058 day-1), it was
significantly higher than the degradations at the 30/65 condition (0.0048 day-1). The results
demonstrated that high temperature and high humidity could also deteriorate the
degradation of the vitamin E succinate powder. Compared to the treatment at 25/60
condition (0.0034 day-1), vitamin E succinate was more susceptible to degradation with
significant higher rate constants at all the other four conditions.
3.4. Conclusion
In conclusion, the encapsulated FSVs were subject to light, temperature, and pH
either in aqueous system or dry form during the storage. When dispersed in aqueous
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system, the encapsulated vitamin A acetate and vitamin A palmitate degraded rapidly in
the presence of light, and the former was relatively more unstable. Compared to the vitamin
A esters, the vitamin D3 and vitamin E succinate exhibited relatively less severe
photochemical degradation. Besides, the effect of pH on the encapsulated FSVs in aqueous
system showed different influence. Vitamin A esters were more unstable in the acidic
conditions than in the alkaline conditions, while vitamin D3 and vitamin E succinate were
susceptible to both alkaline and acidic conditions. Temperature also played an important
role, which can significantly accelerate the degradation of the encapsulated FSVs.
Moreover, the degradations of the FSVs were determined to follow the first-order kinetic
models under the thermal treatments, which corroborated that higher temperature were
linked to higher degradation rate. When the encapsulated FSVs were stored in powder
forms under different temperatures and relative humidity for 93 days, they have shown
different degradation rates, but followed the first-order kinetic models. At the end of the
93-day of the storage, 61.1%, 57.2%, 79.4%, and 71.2% of the four FSVs (vitamin A
acetate, vitamin A palmitate, vitamin D3, vitamin E succinate, respectively) were still
remained at the 25°C/60% RH condition. However, as the temperature and humidity
increased, faster degradation occurred.
It is worthy of mention that, as various encapsulation materials and technologies
have been applied on the commercial market in order to improve the FSVs’ stability, more
research is needed to give deep insights of the protection mechanisms of the FSVs.
Nevertheless, it is important to store the FSVs by appropriate means to prevent them from
degradation.
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Figure 3.2 Photochemical degradations of four FSVs (a. vitamin A acetate, b. vitamin A palmitate, c. vitamin D3, d. vitamin E
succinate) in presence (Light) and in absence (Dark) of light.
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Figure 3.3 Thermal degradations of four FSVs in aqueous system (a. vitamin A acetate, b. vitamin A palmitate, c. vitamin D3,
d. vitamin E succinate) under four different temperatures (25, 30, 40, 60°C). Results expressed as mean with standard
deviation (n=3).
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Figure 3.4 Degradation of the FSVs in aqueous system at four temperatures (25, 30, 40, 60°C) following a first-order kinetic
model
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Table 3.1
Reaction rate constants and coefficients of determination for the four FSVs at different
temperatures (i.e. 25, 30, 40, 60°C)
Temperature
(°C)

Rate constant
(day-1)

R2

Vitamin A Acetate

25
30
40
60

0.398
0.939
1.234
1.515

0.97
0.98
0.98
0.95

Vitamin A Palmitate

25
30
40
60

0.329
0.538
0.610
0.782

0.76
0.97
0.96
0.98

Vitamin D3

25
30
40
60

0.057
0.090
0.091
0.123

0.87
0.96
0.98
0.98

Vitamin E Succinate

25
30
40
60

0.038
0.063
0.094
0.116

0.83
0.91
0.91
0.90

Vitamins
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Figure 3.5 Degradation of FSVs in aqueous system at four pH levels (i.e. pH=3, 5, 7, 9). Results expressed as mean with
standard deviation (n=3).
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Table 3.2
Retention of FSVs powder in different conditions at the end of the designated time pan
(93 days)
Condition

Vit A Ace
(% retention)

Vit A Pal
(% retention)

Vit D3
(% retention)

Vit E Suc
(% retention)

25°C/60% RH

61.1 ± 0.4 a

57.2 ± 3.1 a

79.4 ± 1.2 a

71.2 ± 1.4 a

30°C/65% RH

58.5 ± 1.3 a

47.7 ± 1.4 a

75.9 ± 0.8 b

63.9 ± 0.5 b

30°C/75% RH

21.3 ± 3.7 b

20.3 ± 0.7 b

72.9 ± 0.6 b

57.5 ± 1.5 c

40°C dry

57.0 ± 1.6 a

51.4 ± 4.1 a

75.3 ± 0.7 b

63.7 ± 1.1 b

40°C/75% RH

0

0

69.5 ± 0.8 c

58.9 ± 2.0 bc

Results are presented by mean± standard deviation
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Figure 3.6 Degradation of water dispersible FSVs stored in different conditions followed
by first-order kinetic model (a. vitamin A Acetate; b. vitamin A palmitate)
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Figure 3.6 Degradation of water dispersible FSVs stored in different conditions followed
by first-order kinetic model (c. vitamin D3; d. vitamin E succinate)
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Table 3.3
Reaction rate constants and coefficients of determination (R2) of the four FSV powders stored in five different conditions

Condition

Vitamin A acetate

Vitamin A palmitate

Vitamin D3

Vitamin E succinate

k (day-1)

R2

k (day-1)

R2

k (day-1)

R2

k (day-1)

R2

25°C/60% RH

0.0055 ± 0.0002

0.95

0.0065 ± 0.0003

0.93

0.0023 ± 0.0001

0.92

0.0034 ± 0.0001

0.93

30°C/65% RH

0.0070 ± 0.0003

0.92

0.0097 ± 0.0005

0.93

0.0032 ± 0.0001

0.94

0.0048 ± 0.0002

0.95

30°C/75% RH

0.0141 ± 0.0006

0.92

0.0178 ± 0.0005

0.97

0.0036 ± 0.0001

0.96

0.0058 ± 0.0002

0.92

40°C dry

0.0075 ± 0.0006

0.83

0.0089 ± 0.0008

0.81

0.0033 ± 0.0002

0.87

0.0050 ± 0.0003

0.93

40°C/75% RH

0.0846 ± 0.0055

0.91

0.0939 ± 0.0050

0.91

0.0047 ± 0.0004

0.82

0.0066 ± 0.0004

0.89

Results were presented by mean ± standard error.
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CHAPTER FOUR
STABILITY STUDY OF TWO VITAMIN A ESTERS OF DIETARY SUPPLEMENT
IN SOLID DOSAGE FORM (TABLETS)
Abstract
This study determined the degradation of encapsulated vitamin A acetate and
vitamin A palmitate in the solid dosage form (tablets) of multivitamin/mineral dietary
supplements during a long-term storage period (24 months) under three different
temperature/humidity conditions (i.e., 25°C/60% RH, 30°C/65% RH, 30°C/75% RH)
using five different packaging materials (i.e., glass, HDPE, PETE, blister, METPET/PVDC-PET film pouch). The results indicated that high temperature and humidity
could significantly negatively influenced the degradation of the vitamin A acetate and
palmitate regardless of what materials they were packed by. In addition, the storage time
has exhibited a significant impact on the retentions of those two vitamin A esters. During
the storage under darkness, glass has provided the best protection among all the packaging
materials after 24 months regardless of the storage conditions, which could preserve the
vitamin A acetate and the vitamin A palmitate in a range of 73.10% - 77.33% and 57.71%
- 60.04% of their original amounts, respectively. The degradation rates of the vitamin A
esters under different treatments were determined by fitting the mechanistic growth model
using JMP software, and compared with each other subsequently. In this particular case,
the encapsulated vitamin A acetate exhibited greater stability than the palmitate form.
However, in the real world, the stability performance of the encapsulated vitamin A esters

127

could be affected by other factors such as encapsulating materials and techniques, vendors,
etc.
4.1. Introduction
Deterioration of fat-soluble vitamins (FSVs) in dietary supplements, especially
multivitamin/mineral (MVM) supplements, can occur during their storage due to various
reasons, such as heat, moisture, oxygen, light, metallic ions, oxidizing and reducing agents,
presence of other vitamins or components (e.g. sulphur dioxide), etc (Ottaway, 2010). Even
though the encapsulation technology for the FSVs has been developed in order to extend
the chemical stability, the complexity of the MVM supplements can still induce a certain
degree of degradation of vitamins during their long-term storage. Furthermore, due to the
heterogeneity in terms of chemical structures and properties of various ingredients,
different vitamins deteriorate in different rates. In the meantime, as the use of nutritional
labelling has become mandatory in recent years, it is crucial to determine an accurate
analysis, particularly the stability, of the active ingredients in order to determine the shelf
life of the products. On the other hand, since FDA has suggested that dietary supplements
need to achieve 100% of the active ingredients throughout the expiration period to ensure
the label claims are being satisfied, an overage of the active ingredient is inevitably
required to compensate for any possible losses during the processing, distribution and
storage (Uzzan, Nechrebeki, & Labuza, 2007). However, the overage needed could vary
depend on several factors, such as formulation, storage condition (temperature, humidity),
and packaging types.
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The stability studies are generally conducted for the purpose of shelf life prediction
and labeling suggestion by assessing the effects of environmental factors such as
temperature, relative humidity and container/closure system of the products. According to
the guideline Q1A (R2) of International Council for Harmonisation of Technical
Requirements for Pharmaceuticals for Human Use (ICH), a drug substance is generally
evaluated under certain storage conditions to test its thermal stability as well as its
sensitivity to moisture (ICH, 2003a). Stability studies will be conducted under specific
climatic conditions prevalent in the specific markets. However, the climatic conditions vary
geographically. In order to accurately evaluate the effects of environmental factors on the
stability of the products, the world is divided into four climatic zones (I, II, III, IVa and
IVb) based on the mean kinetic temperature and relative humidity data (ICH, 2003a). For
climatic zone I and II, the recommended long-term storage condition is 25°C/60% RH
(relative humidity), or 30°C/65% RH. Besides those two conditions, the 30°C/75% RH
condition has been recommended as an alternative condition for the climatic zone III (hot
and dry) and IV (hot and humid) (ICH, 2003b). Several studies have reported the effects
of storage conditions on the contents of specific FSVs in powder infant milk, powder
enteral formulas, and FSV fortified wheat flour (Fávaro, Iha, Mazzi, Fávaro, & Bianchi,
2011; Frias, Peñas, & Vidal-Valverde, 2009). However, scarce information has been found
in terms of the vitamin A stability in dietary supplements in different storage conditions.
In this context, the vitamin A content during a long-term storage will be evaluated in the
three aforementioned conditions.
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In addition, packaging materials can provide a barrier to protect the FSVs in the
formulated multivitamin products from oxygen, moisture, and light. However, different
packaging materials perform varying degrees of protection based on their permeability
behaviors. For example, glass is impermeable and able to provide an excellent barrier to
gases and water vapor (Girling, 2003). In comparison, plastic materials are permeable to
small molecules such as water vapor, gases, organic vapor (Siracusa, 2012). Moreover, the
product dosage forms (i.e. soft gel, tablets, and hard-shell capsule) also impact the stability
of the active ingredients in the MVM supplements. For instance, the soft capsules
containing an active ingredient vitamin A in vegetable oil is considered a more stable
environment, although the most popular MVM formula containing other various vitamins
and minerals in a dry matrix is in solid dosage form such as tablets and hard-shells, because
the solid dosage form is a relatively economical form compared to the soft gel form.
In this study, as the most popular and common form, the solid form (i.e., tablets) of
MVM supplements was prepared. These MVM samples were also packaged by five
different packaging materials, including glass, HDPE (high-density polyethylene), PETE
(polyethylene terephthalate), blister, and film pouch made with metallized PET film and
PVDC (polyvinylidene chloride) PET film, and stored in three different conditions
(25°C/60% RH, 30°C/65% RH, 30°C/75% RH) to evaluate the effect of
temperature/moisture condition and packaging materials on stabilities of the test vitamins.
In addition, two different forms of vitamin A esters (i.e., encapsulated vitamin A acetate
and encapsulated vitamin A palmitate) in the MVM supplements were investigated in order
to compare their stability throughout the designated testing period.
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4.2 Materials and Method
4.2.1 Sample preparation
Two multivitamin/mineral (MVM) supplements samples (assigned as sample A
and sample B) in solid dosage form (tablet) were prepared in the Product and Development
Lab at Nutra Manufacturing Inc (Anderson, SC, USA). These two samples were
compressed by the Manesty Press at same force and same speed. These two samples
contained the same components with equal potency, except the form of vitamin A esters.
Encapsulated vitamin A acetate was used in the sample A, whereas encapsulated vitamin
A palmitate was used in the sample B. In addition, both samples contained the same
quantity of other components including vitamin B groups, vitamin C, D, and E, as well as
minerals such as copper, zinc, iron, chromium, iodine. Both of the two vitamin A ester
ingredients were pretreated into particles granulated with a matrix of gelatin, sucrose, and
corn starch, with BHT (<5%) added as antioxidant, except the vitamin A acetate in sample
A containing sodium aluminum silicate additionally.
4.2.2. Sample storage
The MVM tablet samples (i.e., sample A and B) were respectively packaged in
sealed containers made of five different materials: 1) dark-colored glass bottles; 2) darkcolored polyethylene terephthalate (PETE) bottles; 3) white high-density polyethylene
(HDPE) bottles; 4) blister packs then packaged in cartons; and 5) foil/plastic film pouches
then packaged in cartons. Then, 5 bottles/cartons of sample A and sample B in each
packaging were placed in individual chambers with controlled temperature and humidity.
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The environment of the chambers was set at 25°C/60% RH, 30°C/65% RH, 30°C/75% RH,
respectively (denoted 25/60, 30/65, and 30/75).
4.2.3. Stability evaluation
During the designated testing period (24 months), samples were collected from the
chambers at various time intervals (i.e., 0, 0.5, 1, 1.5, 2, 2.5, 3, 6, 12, 18 and 24 month).
Due to the existence of blend variability during tablet manufacturing, it is possible that the
concentration of vitamins in one tablet differs from the other. Therefore, 15 tablets of each
sample from individual bottle/carton were randomly obtained and grounded into powders
for analysis so that higher uniformity could be achieved. Then, 1.0 g of the grounded
powder of the test sample was accurately weighed for subsequent FSVs extraction and
HPLC determination using the optimized method mentioned in Chapter Two.
4.2.4 Statistical Analysis
The effect of storage condition, packaging, and time on stability of the vitamin A
were evaluated using a full factorial design. Statistical analysis was performed using
analysis of variance (ANOVA). Means of remaining quantity of vitamin A under different
treatments were compared using Fisher’s least significant difference (LSD) by JMP, and
p<0.05 was used for assessing the differences. All tests were performed in triplicate.
4.3. Results and Discussion
The effects of storage condition (25/60, 30/65, 30/75), packaging (glass, HDPE,
PETE, blister, pouch) and the storage time on the vitamin A stability were evaluated by a
full factorial design. The ANOVA results indicated that the main effects of storage
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condition, packaging, storage time, as well as their interactions were all significant
(p<0.05).
As shown in Figure 4.1, in all the three conditions (25/60, 30/65, 30/75), the
vitamin A acetate in different packaging materials showed significant deteriorations
throughout 24 months. Previous literature has stated that temperature abuse and increased
moisture content during storage could result in increased reaction rates of vitamin A esters,
which could significantly affect the shelf life of the dietary supplements (Schmidl &
Labuza, 2000). The degradation rate was determined by fitting the mechanistic growth
model of JMP, which has the following equation
!"#"$#%&$ = ( ∙ *1 − - ∙ " !(#∙%&'()) .
where a is the asymptote, b is the scale, and c is the degradation rate. The degradation rate
estimated by the model as well as their 95% confidence interval in each treatment is plotted
in Figure 4.2 in order to compare the stability of the test vitamin A esters. In the diagram,
if there is no overlap between any two lines, then it means no significant difference exists
between the two treatments resulting in the degradation of the vitamin. As a result,
degradation rates of the vitamin A acetate stored under the 30/75 condition exhibited
significantly larger values than those under the 30/65 condition when they were packaged
in glass bottles, HDPE bottles or pouches. When the sample A (containing vitamin A
acetate) was packaged in the PETE bottles, no significant difference of its degradation rates
was found between the three storage conditions. However, the degradation rates of samples
A stored in the 25/60 condition were found to be much lower than those in 30/75, when the
samples were packaged in glass or pouches.
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After 24 months of storage, it was found that the vitamin A acetate retention was
significantly higher when stored in the 25/60 condition than in the 30/65 and 30/75
conditions regardless of the packaging. For example, as shown in Table 4.1, when the
sample A was packaged in glass and stored in the 25/60, its retention (77.33%) was
significantly higher than that stored in the 30/65 and 30/75 conditions (73.52% and
73.10%, respectively). However, the differences of the vitamin A acetate retentions
between the 30/65 and 30/75 treatments varied among the packaging materials used. When
the glass, HDPE and PETE bottles were used, there was no significant difference between
the retention of vitamin A acetate in the 30/65 and 30/75 condition (glass: 73.52% vs 73.10;
HDPE: 69.06% vs 67.50; PETE: 66.07% vs 64.86%). In contrast, significant difference
was observed between the sample A treated with blister packaging in the 30/65 condition
(38.04%) and 30/75 condition (20.97%). In addition, significant difference was found
between the sample A packaged in pouches in the 30/65 condition (11.12%) and 30/75%
condition (0.00%) after 18 months. Particularly, the vitamin A acetate packaged in the
pouches after 18 months in the 30/75 condition was completely degraded (see Figure 4.1).
On the other hand, packaging material, or more specifically, the permeability of the
packaging materials, was found to be another critical factor that could influence the
chemical stability of the active ingredients. When the MVM samples were stored in the
25/60 condition for 24 months, the vitamin A acetate remained in the pouches (32.45%)
was significantly lower than those in the other four packages ranging from 73.21% to
77.33%. In addition, there was no significant difference among the retention values
associated with treatments of glass, HDPE and PETE under the same storage condition
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(i.e., 25/60) (shown in Table 4.1). When the sample A was stored under the higher
temperature and humidity condition (30/75), its retention values associated to the five
packaging treatments were significantly different from each other (p<0.05). It is obvious
that glass has provided the best protection of vitamin A acetate in the sample A with
73.10% of its original content under the 30/75 condition because glass is essentially
impermeable to water vapor and oxygen. In contrast, plastic packaging made with HDPE,
PETE, and blister led to lower retention of the vitamin A acetate (i.e., 67.50%, 64.86%,
and 20.97%, respectively) as a consequence of their permeability to oxygen and water
vapor in various degrees when temperature and humidity is relatively high (i.e., 30/75)
(p<0.05).
Similarly, there were remarkable degradations of the vitamin A palmitate (sample
B) stored in all of the aforementioned conditions and packages throughout the 24 months
(Figure 4.3). During the first 6 months, the vitamin A palmitate rapidly degraded under all
the conditions regardless of the test temperature, humidity and packaging materials. Its
retention value was found in the range of 59.86% - 81.56% when stored in different
packaging materials under the 25/60 condition. In comparison, its remaining amount
decreased to 49.37% -71.48% and 40.05% - 66.28% when stored under the 30/65 and 30/75
conditions, respectively. Based on the analysis of the full factorial design, the storage
condition had a significant effect on the retention of the vitamin A palmitate.
The degradation rates of vitamin A palmitate in sample B was determined using the
same mechanistic growth model, which is plotted and shown in Figure 4.4, where the X
axis represents the estimated degradation rate of the vitamin A palmitate with their 95%
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confidence interval in each treatment. With respect to the glass bottles, no significant
difference of the reaction rates was observed between the aforementioned three storage
conditions. At the same time, degradation rates under both the 30/65 and 30/75 conditions
were proven to be significantly higher than that under the 25/60 condition when the sample
B was stored in the blister and PETE bottles. Moreover, when the vitamin A palmitate was
packaged in the pouch, it was subject to a significantly faster degradation in the 30/75 than
in 25/60 condition.
After 24 months of the treatment (Table 4.2), the remaining amount of vitamin A
palmitate stored under the 30/65 condition was determined to be significantly lower than
that under the 25/60 condition, except that when it was packed in glass. For example, the
vitamin A palmitate stored in HDPE under the 30/65 condition and the 25/60 condition
was determined to remain at 43.34% and 54.38%, respectively. Similarly, it reduced to
40.33% vs 44.74% in the PETE, 31.89% vs 40.68% in the blister, and 1.59% vs 21.27% in
the pouch, respectively. When the external environment reached to an even higher
humidity (e.g., 30/75 condition), the vitamin A palmitate was observed to be significantly
degraded more (p<0.05).
Furthermore, the packaging material has shown a significant influence on the
chemical stability of the vitamin A palmitate. After 24 months of storage, regardless of its
condition, loss of vitamin A palmitate in the samples was significantly lower in glass than
in other packaging materials (Table 4.2). The deterioration of this ingredient ranks in the
following order from slow to rapid speed by HDPE, PETE, blister and pouch for all three
storage conditions (p<0.05). For example, the vitamin A palmitate stored in the 30/65
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condition was degraded to 43.34%, 40.33%, 31.89%, 1.59% of its original value in the
HDPE, PETE, blister and pouch, respectively. At the same time, all of the four
aforementioned results significantly differed from each other. This phenomena clearly
demonstrated the significant effect of packaging materials on the deterioration of vitamin
A palmitate, which was ascribed to their protection properties against oxygen and moisture,
which could promote the oxidation of retinyl palmitate as well as the indirect oxidation
caused by free radicals attack (Hemery et al., 2018).
Both forms of the vitamin A esters (i.e., the acetate form and palmitate form) were
not only observed with significant reductions under all the test conditions, but also they
were significantly different in their remaining amounts under the same treatment. The
acetate form has always exhibited a higher retention value after the 24-month storage
regardless of the packaging and storage conditions. For instance, at room temperature
(25/60), the vitamin A acetate (77.33%) exhibited a significantly higher retention than its
counterpart, vitamin A palmitate (60.04%), when both samples were packaged in glass
(p<0.05). Similarly, when the packaging material for both samples was changed to the
PETE that is more permeable to moisture and oxygen, and the storage condition was
changed to 30/65, the acetate form was degraded to 66.07% of its original amount in
comparison to the palmitate form that was reduced to 40.33% of its original value (p<0.05).
This result is in agreement to a previous study that reported, in a vitamin A fortified flour,
vitamin A acetate was more stable than vitamin A palmitate (Courraud, Berger, Cristol, &
Avallone, 2013), although this finding is different from another study that claimed vitamin
A palmitate had a better stability than the acetate form in fortified salt (Rutkowski &
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Diosady, 2007). Therefore, it is highly possible that, besides the factors of packaging
materials and storage condition, the stability performance of those two forms of the vitamin
A esters might also be affected by other factors such as difference in encapsulation material
and technologies, complexity of food matrices, formulations, vendors, etc., which still need
more investigation. In addition, the vitamin A is generally more stable when encapsulated
in gelatin compared to starch, but the former encapsulation material is excluded for
vegetarian products. On the other hand, different vendors might provide those raw
materials of vitamin A in different quality levels. Therefore, it is critical for the industry to
source stable raw materials for better stability of the vitamin A in the MVM supplements.
4.4. Conclusion
Overall, it is found that packaging materials, storage conditions and storage time
had significant influences on the stability of the vitamin A esters in the MVM sample. The
results confirmed that high temperature and humidity had a negative impact on the vitamin
A retention regardless of what materials it was packed with. When the sample with vitamin
A acetate was packed in plastics (i.e., HDPE, PETE, blister, and pouch), its remaining
amount reduced to 32.45% - 77.29%, 1.58% - 69.06%, and 0% - 67.50% of their original
values under the 25/60, 30/65, and 30/75 condition, respectively. In comparison, the
vitamin A palmitate retention was even worse under the same conditions. Nevertheless,
among all the packaging materials, glass has provided a better protection for the vitamin A
acetate and palmitate with relatively higher retentions ranged from 73.10% to 77.33%, and
57.71% to 60.04% after 24-month storage, respectively.
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It is worth to mention that all of the samples in this present work was stored in
darkness. Even though the glass bottles have provided the best barrier against high
temperature/relative humidity for both samples, some other factors including the exposure
to natural light, product weight, packaging frangibility, and packaging cost need to be
considered into the production in the real world. For instance, HDPE bottles are commonly
used for MVM supplements in the commercial market because of their ability to avoid
photochemical degradation. Taking those considerations into account, prediction of the
shelf life and overage determination will depend on more factors mentioned above, which
need more investigations. Anyway, I sincerely hope this study will provide some useful
information and insights on the protection of FSVs in MVM supplements.
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Figure 4.1 Remaining percentage of sample A (MVM tablet with vitamin A acetate) in five different packaging materials
stored in three conditions (25/60, 30/65, 30/75) throughout 24 months. Results are presented in means with standard deviation
(n=3)
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Figure 4.2 Degradation rates of vitamin A acetate in sample A in different temperature/humidity conditions and packages.
Lines represent the estimated degradation rates with their 95% confidence intervals of vitamin A acetate in each treatment.
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Table 4.1
Vitamin A acetate retention percentage (%) observed after storage for 24 months in five
different packaging materials and three storage conditions

Packaging Material

Storage Condition
25/60

30/65

30/75

Glass

77.33 ± 2.83a

73.52 ± 1.95bc

73.10 ± 2.15c

HDPE

77.29 ± 1.05a

69.06 ± 1.98de

67.50 ± 0.90e

PETE

75.64 ± 2.08ab

66.07 ± 0.99ef

64.86 ± 0.85f

Blister

73.21 ± 0.75bc

38.04 ± 0.85g

20.97 ± 0.28i

Pouch

32.45 ± 0.28h

1.58 ± 0.06j

0.00 ± 0.00j

Results are expressed as means ± standard deviation (n=3). Different letters indicate
significant differences between vitamin A acetate retention (%) in each packaging and
condition.
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Figure 4.3 Remaining percentage of sample B (MVM tablet with vitamin A palmitate) in five different packaging materials
stored in three conditions (25/60, 30/65, 30/75) throughout 24 months. Results are presented in means with standard deviation
(n=3)

143

Vitamin A Palmitate Degradation Rate

Count

30/75

2 HDPE

3 PETE

4 Blister

Condition

1

1 Glass

Condition

30/65

0

Condition

1

Condition

25/60

0

Condition

1

5 Pouch

0

1

25/60

0

1

30/65

0

1

30/75

0

25/60

0

1

30/65

0

1

30/75

0

1

25/60

0

1

30/65

0

1

30/75

0

1

25/60

0

1

30/65

0

1

30/75

0

0.0

0.1

0.2

0.3

Degradation Rate

Packaging

1

0.4

Figure 4.4 Degradation rates of vitamin A palmitate in sample B in different temperature/humidity conditions and packages.
Lines represent the estimated degradation rate with their 95% confidence intervals of vitamin A palmitate in each treatment.
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Table 4.2
Vitamin A palmitate retention percentage (%) observed after storage for 24 months in
five different packaging materials and three storage conditions
Packaging Materials

Storage Condition
25/60

30/65

30/75

Glass

60.04 ± 0.35a

58.11 ± 0.47ab

57.71 ± 0.32b

HDPE

54.38 ± 1.44c

43.34 ± 0.33d

37.84 ± 0.33f

PETE

44.74 ± 2.05d

40.33 ± 1.24e

31.06 ± 0.75g

Blister

40.68 ± 0.71e

31.89 ± 0.80g

23.71 ± 1.71h

Pouch

21.27 ± 1.70i

1.59 ± 0.57j

0.00 ± 0.00j

Results are expressed as means ± standard deviation (n=3). Different letters indicate
significant differences between vitamin A palmitate retention (%) in each packaging and
condition.
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